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Preface 
This PhD thesis investigated the cost-effectiveness of physical activity interventions in the 
culturally diverse setting of Switzerland. After an abstract and an extended summary, the first 
chapter of the thesis elaborates on the background. Afterwards, the specific aims are 
described, which are then followed by the three papers forming part of this thesis. The thesis 
finishes with a chapter that summarizes the main findings, includes a general discussion, 
shows prospects for future research and finally draws overarching conclusions. 
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Abstract 
Before this PhD project started, evidence showed that physical inactivity causes a substantial 
health and economic burden globally. For Switzerland, there was research available 
investigating the burden of physical inactivity. However, this research estimated the burden for 
the entire country without differentiating between sub regions although the prevalence of 
physical inactivity varies significantly between the French-, German- and Italian-speaking 
regions. Therefore, this thesis had three aims: 
1. Estimating the health and economic burden of physical inactivity in Switzerland and for 
the French-, German- and Italian-speaking language regions separately 
2. Systematically reviewing trial-based economic evaluations of interventions to reduce 
physical inactivity 
3. Developing a health economic model that investigates the cost-effectiveness of 
physical activity interventions in Switzerland and its three language regions 
The thesis showed that the burden of physical inactivity in Switzerland is substantial and that 
the French- and Italian-speaking regions are over-proportionally affected. These two regions 
distinguish themselves from the German-speaking region by having a higher prevalence of 
physical inactivity, higher per capita health care spending, and higher disease prevalence. Due 
to the substantial burden of physical inactivity, interventions aiming to increase physical activity 
should be considered. In the systematic review we conducted, we found evidence from 
randomized controlled trials indicating the cost-effectiveness of some physical activity 
interventions for primary prevention in adults. These interventions were then further evaluated 
in a cost-effectiveness model built for the Swiss setting. This model showed that Swiss policy 
makers have cost-effective options of physical activity promotion. We recommend that 
individualized advice and general practitioner referral be further evaluated as interventions and 
that decision-making considers the specifics of the Swiss language regions. Furthermore, we 
judge the cost-effectiveness model to be not only relevant for Switzerland but also for other 
multicultural countries. Based on similar data availability, our model has the potential to be 
applied beyond Switzerland, primarily to high-income countries with a comparable background, 
as a tool to guide societal efforts in primary prevention of physical-inactivity-related diseases. 
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Summary 
Background and aims 
Before this PhD project started, evidence showed that physical inactivity causes a substantial 
health and economic burden globally. For Switzerland, there was research available 
investigating the burden of physical inactivity. However, this research estimated the burden for 
the entire country without differentiating between sub regions although the prevalence of 
physical inactivity varies significantly between the French-, German- and Italian-speaking 
regions. Therefore, the aim of the first publication forming part of this PhD thesis was to 
estimate the burden of physical inactivity in Switzerland separately for the three language 
regions. In a systematic review that formed the basis of the second publication of this thesis, 
we aimed to identify cost-effective physical activity interventions that have been investigated 
in randomized controlled trials (RCTs). We then moved on and used findings from the first two 
PhD publications to develop a health economic model that investigates the cost-effectiveness 
of physical activity interventions in Switzerland and its three language regions. 
Publication 1: Burden of physical inactivity in Swiss language regions 
We estimated the burden of physical inactivity in Swiss adults from a societal perspective with 
a prevalence‑based top‑down approach using population attributable fractions (PAFs) and the 
latest data available for Switzerland. The following nine diseases related to physical inactivity 
were included in the analysis: coronary heart disease, hypertension, ischemic stroke, type 2 
diabetes mellitus, breast cancer, colorectal cancer, osteoporosis, low back pain, and 
depression. Total disability-adjusted life-years (DALYs), health care costs, and productivity 
losses of these diseases were then retrieved from the global burden of disease study and a 
recent study on the costs of non-communicable diseases in Switzerland. In order to analyze 
the fraction of this total burden that is attributable to physical inactivity, we combined estimates 
of the prevalence of physical inactivity stemming from the Swiss Health Survey with literature‑
based estimates of disease incidence in the presence vs. absence of physical inactivity and 
resulting relative risks. The combination of these two types of parameters allowed us to 
estimate PAFs, which describe the proportion of disease occurrence that can be attributed to 
a certain risk factor.  
The burden of physical inactivity in Switzerland in 2013 was estimated at CHF 1.610 billion 
(95%CI CHF 1.413‑1.827 billion) plus 40,433 (95%CI 34,935‑46,487) DALYs. The DALYs lost 
due to physical inactivity represented 2.0% (95%CI 1.7%‑2.2%) of total DALYs lost in 
Switzerland. Health care costs caused by physical inactivity were estimated at CHF 0.802 
billion (95%CI CHF 0.684‑0.934 billion) or at 1.2% (95%CI 1.0%‑1.3%) of total health care 
expenditures. This was equivalent to CHF 116 (95%CI CHF 99‑135) per capita. Productivity 
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losses were valued at CHF 0.808 billion (95%CI CHF 0.653‑0.983 billion) or CHF 117 (95%CI 
CHF 94‑142) per capita. Furthermore, we found that the French‑ and Italian‑speaking regions, 
which are home to 30% of the Swiss population, contribute more than 45% to the burden of 
physical inactivity. Reasons include a higher prevalence of physical inactivity, higher per capita 
health care spending, and higher disease prevalence than the German‑speaking region. In 
addition, the per capita burden was twice as high in the French- and Italian-speaking regions 
compared to the German-speaking region. 
In conclusion, this study showed that physical inactivity causes a substantial health and 
economic burden in Swiss adults and that the French‑ and Italian‑speaking regions are over- 
proportionally affected. Investments in interventions aiming to increase physical activity should 
therefore be considered. Such interventions should be cost-effective and this study indicates 
that regional differences likely influence the cost-effectiveness of physical activity 
interventions.  
Publication 2: Systematic review of cost-effectiveness of physical activity interventions 
In this systematic review, we aimed to summarize evidence from RCT-based economic 
evaluations of primary prevention physical activity interventions in adult populations outside 
the workplace setting. We included cost-effectiveness analyses in which all data (except unit 
costs) came from one RCT. As the studies reported different physical activity outcomes, effect 
measures were standardized in metabolic equivalent of task (MET)-hours gained per person 
per day. We further calculated the mean differences in costs and outcomes between 
intervention and control as a basis for estimating the incremental cost-effectiveness ratio 
(ICER) in US$ per MET-hour gained. A benchmark between US$0.44 and US$0.63 per MET-
hour gained, which was based on the health care costs and productivity losses of physical 
inactivity in Switzerland, was used to assess the cost-effectiveness of interventions. 
Twelve studies published between 2000 and 2018 were included in the final analysis. In these 
twelve studies, 22 interventions were investigated. Interventions were based on advice, goal 
setting and follow-up support, exercise classes, financial incentives or teaching on behavioral 
change. The effects and costs of the interventions varied widely and so did the ICER. Four 
interventions showed an ICER below the applied benchmark. These four interventions were 
based on individualized advice delivered in four different ways: print (postal mail) or web 
(website and email) and in a basic form (standard advice) or with additional environmental 
components (e.g., walking and cycling routes). One other intervention that was based on 
general practitioner (GP) referral to behavior change counseling by telephone had an ICER of 
US$0.64 per MET-hour gained. One pedometer-based individualized goal-setting intervention 
had an ICER of US$0.67 per MET-hour gained. Another intervention was based on exercise 
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prescription and had an ICER of US$0.85 per MET-hour gained. All other interventions had an 
ICER above US$1.00 per MET-hour gained. 
In conclusion, we found evidence from RCTs indicating cost-effectiveness of some physical 
activity interventions for primary prevention in adults. However, cost-effectiveness results 
varied widely among interventions and the majority of interventions would not be cost-effective 
according to the benchmark applied. Four interventions that delivered individualized advice via 
print or web showed the best value (physical activity gains) for money (intervention costs). 
Publication 3: Cost-effectiveness model of physical activity interventions 
The cost-effectiveness model of physical activity interventions was built as a proportional 
multistate life table model for the Swiss adult population over their lifetime. We named it the 
Swiss Physical Activity Cost-Effectiveness (SPACE) model. In the model, a comprehensive 
set of diseases was included, namely breast cancer, colorectal cancer, type 2 diabetes 
mellitus, coronary heart disease, ischemic stroke, osteoporosis, low back pain and depression. 
The effect of interventions on diseases was modelled with data from recent meta-analyses. 
Interventions analyzed were individualized physical activity advice, pedometer with 
individualized goal setting, GP referral to telephone-based counseling and exercise 
prescription. Intervention effects were taken from RCTs, and intervention costs were based on 
a bottom-up approach with Swiss prices. Cost-effectiveness in terms of cost per DALY averted 
compared to “doing nothing” as well as cost-effectiveness between interventions were 
analyzed on the national level and separately for the French-, German- and Italian-speaking 
language regions. The frequently assumed tentative willingness-to-pay threshold of CHF 
100,000 per DALY was used to assess the cost-effectiveness of interventions. Interventions 
that led to better health and were at the same time cost-saving were categorized as “dominant”. 
From a societal perspective and irrespective of language region, all four interventions were 
cost-saving and more effective compared to “doing nothing”. At the national level and in the 
German-speaking region, individualized advice was the preferable intervention followed by GP 
referral. These two interventions dominated pedometer and exercise prescription. In the 
French- and Italian speaking regions, GP referral was the preferable intervention that 
dominated the three others. From a health care payer perspective, however, individualized 
advice was the preferable intervention followed by GP referral. The uncertainty underlying key 
model input parameters led to substantial variation in the modelled results, according to the 
probabilistic sensitivity analysis. 
In conclusion, we hope to inform efficient resource allocation and evidence-based decision-
making in primary prevention in Switzerland. We recommend that individualized advice and 
GP referral be further evaluated as interventions and that decision-making considers the 
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specifics of the Swiss language regions. Furthermore, we judge the SPACE model to be not 
only relevant for Switzerland but also for other multicultural countries. Based on similar data 
availability, the SPACE model has the potential to be applied beyond Switzerland, primarily to 
high-income countries with a comparable background, as a tool to guide societal efforts in 
primary prevention of physical-inactivity-related diseases. 
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 Background 
 Switzerland - a multilingual, multicultural country 
Switzerland has a population size of about 8.5 million [4]. Influenced by its neighboring 
countries, there are three main language regions in this rather small country: German-
speaking, French-speaking and Italian-speaking (Figure 1). The fourth national language is 
Romansh, which is spoken by a minority of about 0.5% of the population [5]. There are also 
many foreigners contributing to the linguistic diversity of Switzerland. The most commonly 
spoken foreign languages are English, Portuguese, Spanish, Serbian, Croatian and Albanian 
[5]. The relationship between language and culture has been extensively studied [6] and recent 
concepts suggest an interactional relationship between the two [7]. Due to its linguistic 
diversity, Switzerland can be considered a culturally diverse setting. 
Figure 1: Switzerland and its three main language regions 
 
Interestingly, we see substantial differences in health behavior, self-perceived health status 
and health care resource use between the language regions. Examples include prevalence of 
smoking, alcohol abuse, unhealthy eating habits and physical inactivity that are on average 
higher in the French- and Italian-speaking regions compared to the German-speaking region 
[8]. Furthermore, self-perceived health status is highest in the German-speaking region, 
followed by the French-speaking and Italian-speaking regions [8]. In addition, there are more 
doctor’s visits per year in the French- and Italian-speaking regions than in the German-
speaking region [8]. Research also showed variation in the cost of care during the last year of 
life between Swiss language regions and highlighted the importance of cultural factors for the 
delivery and utilization of health care [9]. 
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 The relevance of non-communicable diseases in Switzerland 
Switzerland has the second highest life expectancy worldwide, which is 84 years [10]. 
However, Switzerland also has the second highest health care expenditure with US$ 9836 per 
capita [11]. Non-communicable diseases (NCDs) such as cardiovascular diseases, 
musculoskeletal diseases and neoplasms cause 80% of the health and economic burden in 
Switzerland (Figure 2) [12, 13]. This substantial burden is the reason for the strategic initiative 
for the prevention of NCDs by the Swiss Federal Office of Public Health [14]. 
In addition to personal and environmental factors, modifiable lifestyle factors influence the 
incidence of NCDs and life expectancy [15-19]. Modifiable lifestyle factors include smoking, 
alcohol abuse, unhealthy eating habits and physical inactivity. All these lifestyle factors are 
common in Switzerland [8]. Furthermore, the health and economic burden due to smoking, 
alcohol abuse and physical inactivity has been shown to be substantial [20-22]. This PhD 
project focuses on one of these lifestyle factors: physical inactivity. 
Figure 2: Health care expenditure in Switzerland by disease group and disease (from Wieser et al. [13]) 
 
 
 Physical activity 
Physical activity is defined as bodily movement produced by skeletal muscles that results in 
energy expenditure [23]. Physical activity occurs for different reasons in different domains 
throughout the day. The four domains are occupational, transportation, household and leisure-
time physical activity [24]. 
Physical activity is associated with a wide range of health benefits. Higher levels of physical 
activity lead to reduced all-cause mortality [25-29]. Furthermore, physical activity reduces the 
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risk of several NCDs such as coronary heart disease, ischemic stroke, type 2 diabetes mellitus, 
colorectal cancer, breast cancer, depression and low back pain [30-32]. 
Due to the health-enhancing effects of physical activity, the world health organization (WHO) 
recommends at least 2.5 hours of physical activity with moderate intensity per week or 
1.25 hours of physical activity with high intensity per week [33]. These WHO guidelines have 
been adopted by the Swiss Federal Office of Sports [34]. Most recent recommendations have 
been issued for the US [35]. The US guidelines specify higher levels of physical activity: adults 
should do at least 2.5 hours to 5 hours a week of moderate-intensity, or 1.25 hours to 2.5 hours 
a week of vigorous-intensity physical activity, or an equivalent combination of moderate- and 
vigorous-intensity activity. Adults should also do muscle-strengthening activities on two or 
more days a week. Children and adolescents should be physically active for at least one hour 
per day. 
 
 Physical inactivity in Switzerland 
Physically inactive people do not comply with physical activity recommendations. Although 
physical inactivity can be considered a global pandemic, the problem is of particular concern 
in high-income countries. In 2016, the prevalence of physical inactivity in high-income 
countries was twice that in low-income countries (36.8% versus 16.2%) [36].  
In Switzerland, 24.3% of the population over the age of 15 is physically inactive [8]. However, 
the prevalence of physical inactivity shows significant regional differences: 21.0% of the adult 
population in the German-speaking region is physically inactive whereas 32.6% are physically 
inactive in the French-speaking region and 31.5% in the Italian-speaking region. These 
regional differences can also be seen in children: during an average school day, 21% of the 
children in the German-speaking region are physically active for less than one hour whereas 
this number is 31% in the other two language regions [37]. People with higher education and 
higher income generally tend to be more active. Recent studies, however, showed that the 
regional differences of physical inactivity in Switzerland cannot be explained by such socio-
demographic differences or differences in the built environment [38-41]. 
 
 The burden of physical inactivity in Switzerland 
Cost-of-illness studies estimate the burden of specific health problems at the population level 
in terms of losses of quality and length of life, health care resource use and productivity losses. 
Cost-of-illness studies are often used to demonstrate the importance of particular health 
problems to policy makers and the public. In these circumstances, the magnitude of a health 
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problem is used to justify or guide resource allocation, e.g. the allocation of 
intervention/prevention programs or the allocation of research funding [42, 43]. Although cost-
of-illness studies are of a descriptive nature, they can also be used to analyze the magnitude 
of a certain aspect of a health problem. In addition, cost-of-illness studies define the upper limit 
of resources that could be saved through interventions and therefore serve as a framework for 
cost-effectiveness analyses of interventions [44, 45]. 
The global burden of physical inactivity is substantial. In 2015, 1.6 million deaths and 
34.6 million disability-adjusted life-years (DALYs) were attributable to physical inactivity [46]. 
Furthermore, the health problem is getting worse as deaths and DALYs attributable to physical 
inactivity increased by more than 17% between 2005 and 2015. The major health burden of 
physical inactivity has also been shown in other studies [47]. Besides the substantial health 
burden, physical inactivity also causes an associated economic burden worldwide [48-50]. 
In a recent study, we estimated health care costs due to physical inactivity at CHF 1.2 billion 
or at 1.8% of total health care expenditures in Switzerland in 2011 and productivity losses at 
CHF 1.4 billion [22]. Furthermore, 326,310 cases of disease and 1,153 deaths were attributable 
to physical inactivity in 2011. Although the prevalence of physical inactivity varies significantly 
between Swiss language regions, this study estimated costs for the entire country without 
differentiating between sub regions. Therefore, the aim of the first publication forming part of 
this PhD thesis was to estimate the burden of physical inactivity in Switzerland separately for 
the German-, French- and Italian-speaking regions.  
 
 Physical activity interventions 
Physical activity behavior is determined by individual, social and environmental factors (Figure 
3) [51]. Physical activity interventions initially were targeting individual-level health, and 
interventions intending to change physical activity on a population level emerged later. More 
recently, a systems approach that acknowledges the complex interaction of individual- and 
population-level interventions has been promoted (Figure 4) [52]. In accordance with this 
systems approach, the Global Advocacy for Physical Activity defined the following seven “best 
investments” for physical activity with good evidence of effectiveness and worldwide 
applicability: school-based interventions, transport, urban design, primary health care, public 
education (including mass media), community-based interventions (including workplace) and 
the sports system [53].  
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Figure 3: Adapted ecological model of the determinants of physical activity (from Bauman et al. [51]) 
 
Reprinted from The Lancet 2012. 380(9838):258-71, with permission from Elsevier 
Figure 4: Systems approach to physical activity (from Kohl et al. [52]) 
  
Reprinted from The Lancet 2012. 380(9838):294-305, with permission from Elsevier 
There are hundreds of primary studies investigating the effectiveness of physical activity 
interventions, and it is not surprising that systematic reviews are also numerous [54-71]. 
However, with limited resources available, policy makers are interested in interventions that 
provide best value for money. Therefore, interventions aiming to increase physical activity 
should not only prove effectiveness in terms of health outcomes but also cost-effectiveness. 
 
 Cost-effectiveness analyses 
Cost-effectiveness analyses compare costs and outcomes of an intervention with a comparator  
and are also called full economic evaluations [72]. In full economic evaluations, costs can be 
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reported from different perspectives, e.g. intervention costs, health care costs offset due to 
interventions or productivity losses offset due to interventions. There are also different outcome 
measures that can be used such as MET-hours per week gained, DALYs averted or quality-
adjusted life-years (QALYs) gained (strictly, the latter two would be named cost-utility analyses 
instead of cost-effectiveness analyses). The difference in costs between intervention and 
comparator is divided by the difference in the effect between intervention and comparator to 
estimate the incremental cost-effectiveness ratio (ICER). The ICER describes how much it 
would cost to gain one MET-hour per week, how much it would cost to avert one DALY or how 
much it would cost to gain one QALY. This ICER can then be compared between interventions 
in order to find the most cost-effective one. Some countries also know an ICER threshold and 
if the ICER of an intervention lies above this threshold, the intervention is no longer considered 
to be cost-effective. Consequently, cost-effectiveness analyses investigate value for money. 
However, there is a second relevant question in economic evaluations and that is the one 
about affordability. Affordability is investigated in budget impact analyses. Budget impact 
analyses estimate expected changes in health care expenditure after the introduction of a new 
intervention [73]. However, a budget impact analysis can also be useful for budget or resource 
planning.  
There are two different approaches in economic evaluations: trial-based economic evaluations 
and model-based economic evaluations [74]. However, the transition between the two is 
smooth. In a trial-based economic evaluation, costs are measured alongside a clinical trial 
investigating the effect of the intervention [75-78]. In a model-based economic evaluation, data 
on the effect and the costs from different sources are combined in a decision-analytic model 
[79, 80]. Both methodological approaches have strengths and weaknesses [81-85]. The main 
strengths of a trial-based economic evaluation are related to the methodological strength of 
randomized controlled trials (RCTs), i.e. the exclusion of potential biasing factors [80]. 
However, RCTs have weaknesses when directly used for policy making that are related to the 
efficacy versus effectiveness discussion [80]: areas of potential concern include choice of 
comparator, protocol-driven costs and outcomes, artificial environment, intermediate versus 
final outcomes, inadequate participant follow-up, and selected patient and provider populations 
[80]. Model-based economic evaluations have the strength that they can synthesize the best 
evidence available in case relevant head-to-head clinical trials are missing, costs were not 
measured within trials, intermediate endpoints were captured or trial follow-up was short-term 
[74]. Nevertheless, inappropriate use of clinical data, bias in observational data, difficulties of 
extrapolation and concerns about transparency or validity of models are major problems [74]. 
These strengths and weaknesses make it evident that for policy-making reasons the two 
methods are better used complementarily than alternatively [81]. 
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Several systematic reviews have investigated the cost-effectiveness of physical activity 
interventions [86]. Most reviews focused on specific settings (e.g. school, workplace, 
community) and did not pay much attention to the methodological approaches (trial-based or 
model-based) chosen in the identified economic evaluations [86]. The availability of trial-based 
economic evaluations of physical activity interventions seems to be limited [54, 60, 87, 88], 
and to the best of our knowledge, no systematic review has focused on this topic. 
Consequently, the second publication forming part of this PhD thesis aimed to systematically 
review trial-based economic evaluations of interventions to increase physical activity. 
 
 Modelling cost-effectiveness of physical activity interventions 
Policy makers have to make decisions on a national or even regional level and cost-
effectiveness of physical activity interventions may differ between regions. This could be 
specifically the case in Switzerland where the prevalence of physical inactivity but also health 
care resource use substantially differs between language regions. Therefore, policy makers 
need to know the cost-effectiveness of physical activity interventions regionally in order to 
allocate resources efficiently. Health economic modelling can support decision-making, 
particularly in the absence of region-specific data [74, 79]. 
A variety of model structures have been presented for the economic evaluation of public health 
interventions for NCDs [89]. Previous models investigating the cost-effectiveness of physical 
activity interventions include decision trees [90, 91], Markov models [92-96], microsimulation 
models [97, 98] as well as multistate life table models [99-102]. Most models were built for the 
UK [90-94, 97-99, 103-108], Australia [100, 102, 109-111] and the USA [96, 112-114]. 
However, no such model is yet available for Switzerland. Therefore, the aim of the third 
publication forming part of this PhD thesis was to develop a health economic model that 
investigates the cost-effectiveness of physical activity interventions in Switzerland and its three 
language regions. 
To the best of our knowledge, all previous models investigating physical activity interventions 
were built from a health care payer perspective. Therefore, our aim was to develop a model 
not only from a health care payer perspective but also from a societal one, meaning we also 
included productivity losses [115]. Furthermore, we aimed to account for the fact that the use 
of certain resources does not increase when scaling up the interventions (fixed costs) [115]. 
The term ‘scaling up’ describes “the ambition or process of expanding the coverage of health 
interventions, but can also refer to increasing the financial, human and capital resources 
required to expand coverage” [116] and it originates from the time when the HIV/AIDS 
pandemic was the most relevant public health issue. Nowadays, physical inactivity is also seen 
as a pandemic and it is not surprising to see similar considerations regarding scaling up of 
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interventions in this field [52, 117, 118]. It is suggested that cost-effective and financially 
feasible interventions should be considered for scaling up [119-121].  
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 Aims 
The aims of this PhD project were: 
1. Estimating the health and economic burden of physical inactivity in Switzerland and for 
the French-, German- and Italian-speaking language regions separately 
2. Systematically reviewing trial-based economic evaluations of interventions to reduce 
physical inactivity 
3. Developing a health economic model that investigates the cost-effectiveness of 
physical activity interventions in Switzerland and its three language regions 
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1 |  INTRODUCTION
Physical inactivity is a major risk factor for numerous non‐
communicable diseases, which are responsible for a large 
share of the morbidity and mortality in Switzerland.1 The 
prevalence of physical inactivity in adults in Switzerland is 
28% but differs substantially among the three language re-
gions (German‐, French‐, and Italian‐speaking).2 In fact, 
language region has been shown to be a strong correlate of 
physical activity independent of socio‐demographic or en-
vironmental factors.3 For example, French‐speaking parents 
have been observed to be more likely to drive their children 
to school compared to German‐speaking parents, indicating 
that habits and beliefs about the proper way of performing 
everyday tasks may differ between Swiss language regions.4 
Differences in habits and beliefs are often referred to as cul-
tural differences and have been shown to influence physical 
activity behavior.5 Therefore, Switzerland and its language 
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Physical inactivity is a major risk factor for numerous non‐communicable diseases 
which dominate the overall burden of disease in Switzerland. We aimed to estimate 
the burden attributable to adult physical inactivity in Switzerland and its three cultur-
ally different language regions from a societal perspective in terms of disability‐ad-
justed life years (DALYs), medical costs, and productivity losses. The burden of 
physical inactivity was estimated with a population attributable fractions (PAFs) ap-
proach. PAFs were calculated based on the prevalence of physical inactivity in the 
Swiss Health Survey and literature‐based adjusted risk ratios of disease incidence. 
These PAFs were then applied to the total burden of the diseases related to physical 
inactivity. Physical inactivity was responsible for 2.0% (95%CI 1.7%‐2.2%) of total 
DALYs lost and 1.2% (95%CI 1.0%‐1.3%) of total medical costs in 2013. This is 
equivalent to 116 (95%CI 99‐135) Swiss francs per capita per year. Productivity 
losses were valued at 117 (95%CI 94‐142) Swiss francs per capita per year. The two 
diseases which caused the highest economic burden were low back pain and depres-
sion. The analysis of regional differences revealed that the per capita burden of phys-
ical inactivity is about twice as high in the French‐ and Italian‐speaking regions 
compared to the German‐speaking region. Reasons include a higher prevalence of 
physical inactivity, higher per capita health care spending, and higher disease preva-
lence. Cost‐effectiveness analysis of related interventions should consider regional 
differences for optimal resource allocation in physical activity promotion policies.
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regions form an interesting case for analyzing the influence 
of cultural differences on the burden of physical inactivity 
especially as nationwide health policies and regulations apply 
(including health insurance law and benefit package) and uni-
form nationwide data exist.
Disability‐adjusted life years (DALYs) in combination 
with economic burden can be used to measure the burden 
of a disease or a health behavior such as physical inactivity 
imposes on society.6 DALYs combine in one measure years 
of life lost due to premature mortality (YLL) and years lived 
with disability (YLD). Therefore, they measure the difference 
between the current situation and an ideal situation in which 
everyone would live up to the age of standard life expectancy 
and in perfect health. The economic burden is described by 
medical costs and productivity losses caused by the disease 
or health behavior.
An early study estimated the economic burden of phys-
ical inactivity in Switzerland at 2.384 billion Swiss francs 
in the year 2000.7 However, this study did not analyze lan-
guage region‐specific differences and did not estimate 
DALYs. Furthermore, the prevalence of physical inactivity 
has decreased over the last years. Although this decrease 
can be observed in all language regions, the gap between the 
German‐speaking region, where the prevalence of physical 
inactivity is lower, and the French‐ and Italian‐speaking re-
gions is widening.2
A better understanding and awareness of the regional 
differences in the burden of physical inactivity and their 
consequences are needed to support the optimal alloca-
tion of resources in physical activity promotion policies in 
Switzerland and might also be of interest for other multi-
cultural societies. Furthermore, this study contributes to the 
international literature by considering some conditions not 
included in many previous studies, namely low back pain and 
depression, using population attributable fractions (PAFs) 
based on risk ratios (RR) adjusted for confounders and ad-
dressing uncertainty with sensitivity analyses to estimate ro-
bust and transparent results.8 This study estimates the current 
Disability‐adjusted life years, medical costs and productivity 
losses of physical inactivity in Switzerland and for the three 
language regions separately.
2 |  MATERIALS AND METHODS
2.1 | Overview
We estimated the burden of physical inactivity from a soci-
etal perspective with a prevalence‐based top‐down approach 
using population attributable fractions (PAFs) and the lat-
est data available for Switzerland. In a first step, we identi-
fied from previous studies the diseases for which physical 
inactivity is a recognized risk factor. Total DALYs, medi-
cal costs, and productivity losses of these diseases were then 
retrieved from the global burden of disease (GBD) study 
and a recent study on the costs of non‐communicable dis-
eases in Switzerland.1,9 In order to analyze the fraction of 
this total burden that is attributable to physical inactivity, we 
combined estimates of the prevalence of physical inactivity 
stemming from the most recent Swiss Health Survey with 
literature‐based estimates of disease incidence in the pres-
ence vs. absence of physical inactivity and resulting risk ra-
tios (RR). The combination of these two types of parameters 
allowed us to estimate PAFs, which describe the proportion 
of disease occurrence that can be attributed to a certain risk 
factor. In other words, the PAFs describe the proportion of a 
disease occurrence that could be prevented by entirely elimi-
nating the risk factor for physical inactivity. Figure 1 gives 
an overview of the methods. This study follows the recently 
published checklist for reporting estimates of the economic 
burden of risk factors.8
2.2 | Diseases included in the analysis
Epidemiological studies consistently show substantial as-
sociation between physical inactivity and the occurrence of 
the following diseases: coronary heart disease, hypertension, 
stroke, diabetes type 2, breast cancer, colon cancer, osteo-
porosis, back pain, and depression. We included all of these 
nine diseases in our analysis. Most of these diseases were 
also considered in previous studies investigating the bur-
den of physical inactivity.6,10,11 However, only one previous 
study included back pain and depression.7 Although these 
two diseases have no impact on mortality, they incur a sub-
stantial economic burden due to high treatment costs and pro-
ductivity losses.9 Consequently, we decided to include them 
as well.
2.3 | National data on economic cost and 
health burden of diseases
Estimates of the annual total medical costs of the diseases 
for which physical inactivity is a recognized risk factor stem 
from the most recent study on the costs of non‐communicable 
diseases in Switzerland.9 This study took into account total 
medical costs of all health care services (inpatient and out-
patient services and drugs), irrespective of the actual payer. 
Costs for hypertension were not reported in this study. We 
therefore used estimates from a recent study specifically in-
vestigating costs of antihypertensive therapy in Switzerland.12 
In our study, we extrapolated all costs to the year 2013 based 
on the increase in health care spending.
Annual productivity losses were estimated with a human 
capital approach. For all diseases except hypertension, results 
from the above‐described study by Wieser et al9 were used. 
To estimate productivity losses for hypertension, we used the 
Cause of Death Statistic, the Swiss Labor Force Survey and 
   | 97MATTLI eT AL.
the Swiss Earnings Structure Survey.13-15 Future productivity 
losses due to premature mortality were discounted to pres-
ent value at a 2% rate. Details are described in Supporting 
Information Section 1. We extrapolated productivity losses to 
the year 2013 according to the nominal wage increase.
We estimated DALYs per disease based on the GBD study 
2013.1 We used the following groups: hypertensive heart dis-
ease for hypertension, ischemic heart disease for coronary 
heart disease, ischemic stroke for stroke, diabetes mellitus for 
diabetes type 2, breast cancer for breast cancer, colon and 
rectal cancer for colon cancer, falls for osteoporosis, low back 
pain for back pain, and depressive disorders for depression.
2.4 | Estimation of burden per 
language region
We divided the national disease burden by the number of prev-
alent disease cases in Switzerland (Supporting Information 
Section, Table S1) and then multiplied the resulting burden 
per case (Supporting Information Section, Table S2) with the 
number of prevalent disease cases in each language region to 
estimate the regional disease burden. The prevalent disease 
cases were estimated from the data of the 2012 Swiss Health 
Survey and the National Institute for Cancer Epidemiology 
and Registration.16-18 Details about this survey are described 
in Supporting Information Section 2. All prevalence of dis-
ease data were adjusted for the year 2013 based on population 
data from the Swiss Federal Statistical Office. To allow for 
regional differences in health care spending, we estimated 
age‐ and gender‐standardized per capita health care spending 
for each language region based on the statistics of the Swiss 
risk compensation scheme.19 For the productivity losses, 
we considered regional differences by estimating median 
wages for each language region based on the Swiss Earnings 
Structure Survey.15
2.5 | Prevalence of physical inactivity
We estimated the prevalence of physical inactivity in cases 
eventually developing a given disease of interest by per-
forming a propensity score matching using the data of the 
2012 Swiss Health Survey.16,20 This survey identified self‐
reported physical activity levels. A person was considered 
as physically inactive, if she/he did not meet the current 
minimal recommendations for health‐enhancing physi-
cal activity by the WHO21: at least 2.5 hours of physical 
activity with moderate intensity per week or 1.25 hours of 
sports with high intensity per week. Covariates included 
in the propensity score matching were behavior (smoking, 
alcohol use, eating habits, lifestyle), personal characteris-
tics (sex, bmi, education), and environmental factors (stress 
at work, language region, urban/rural). More details about 
the propensity score matching can be found in Supporting 
Information Section 3.
F I G U R E  1  Overview of methods. The burden of disease in the total population was extracted from literature (1). The prevalence of physical 
inactivity in the Swiss Health Survey (2) and literature‐based risk ratios of disease incidence (3) were then combined to get the population 
attributable fraction (PAF) (4). In the last step, the PAF was multiplied with the disability‐adjusted life years (DALYs), medical costs and 
productivity losses in the total population to estimate the burden attributable to physical inactivity (5)
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2.6 | Quantification of risk ratios
We quantified the confounding‐adjusted RR for disease inci-
dence resulting from physical inactivity vs. physical activity 
based on previously published meta‐analyses investigating 
causality between physical activity and a specific disease 
(Table 1). Where RR were estimated for different exposure 
levels, we used the ones closest to our definition of physical 
activity and inactivity. In case the RR was reported for ac-
tive people, we used the following formula to obtain the RR 
for inactive people: RR(inactive) = 1/RR(active).
2.7 | Calculation of population 
attributable fractions
We estimated the population attributable fractions (PAFs) 
based on the prevalence of physical inactivity reported 
in the latest Swiss Health Survey and RR for disease inci-
dence extracted from the literature. PAFs can be calculated 
with different formulae. The most common formula uses the 
prevalence of the exposition in the total population and the 
unadjusted RR (formula (1)).
The unadjusted RR do not account for confounding be-
tween exposure and disease. Consequently, this formula is 
only valid if there is no risk of confounding of the associ-
ation between exposure and disease.22,23 In the context of 
physical inactivity, most recent studies recommend using an 
alternative formula (formula (2)).6,24 This formula considers 
the prevalence of the exposition in cases finally developing 
the disease together with the RR adjusted for confounding. In 
our study, we used formula (2) to calculate PAFs related to 
physical inactivity.
2.8 | Sensitivity analysis
We conducted two scenario analyses and a probabilistic sen-
sitivity analysis. In scenario analysis 1, we used PAF formula 
(1) instead of formula (2) to analyze the influence of the for-
mula on the national burden of disease attributable to physi-
cal activity. In scenario analysis 2, we assumed that the only 
difference between the language regions would be the preva-
lence of physical inactivity. Therefore, in scenario analysis 
2, we neglected the fact that there are differences in disease 
prevalence, differences in per capita health care spending, 
and differences in salaries among the three language regions. 
The probabilistic sensitivity analysis was conducted to es-
timate 95% credible intervals (CI). We used the following 
distributions for this analysis: lognormal distribution for the 
RR, beta distribution for the prevalence of physical inactiv-
ity, uniform distribution for the medical costs and the produc-
tivity losses, and gamma distribution for the DALYs. 10 000 
Monte Carlo simulations were run. The entire model includ-
ing the sensitivity analyses was implemented in Excel 2010 
(Microsoft, Redmond, Washington, USA).
3 |  RESULTS
3.1 | National burden due to physical 
inactivity
On a national level, we estimated PAFs for physical in-
activity at 4.1% (95%CI 1.7%‐6.3%) for back pain, 4.3% 
(95%CI 1.2%‐7.2%) for coronary heart disease, 5.0% (95%CI 
2.6%‐7.1%) for depression, 5.3% (95%CI 2.7%‐7.8%) for dia-
betes type 2, 5.4% (95%CI 2.5%‐8.3%) for stroke, 6.7% (95%CI 
(1)
PAF (%)=
prevalenceexposition total population
(
RRunadj−1
)
prevalenceexposition total population
(
RRunadj−1
)
+1
×100
(2)PAF (%)=
prevalenceexposition in cases
(
RRadj−1
)
RRadj
×100
Disease RR‐value
95% CI lower 
bound
95% CI 
higher bound References
Hypertension 1.36 1.28 1.45 Janssen11
Coronary heart 
disease
1.16 1.04 1.30 Sattelmair et al40
Stroke 1.18 1.08 1.28 Wendel‐Vos et al41
Diabetes type 2 1.20 1.10 1.33 Jeon et al42
Breast cancer 1.33 1.26 1.42 Lee et al24
Colon cancer 1.32 1.23 1.39 Wolin et al43
Osteoporosis 1.57 1.38 1.77 Janssen11
Back pain 1.16 1.06 1.27 Shiri and 
Falah‐Hassani44
Depression 1.20 1.11 1.32 Schuch et al45
T A B L E  1  Risk ratios (RR) for disease 
incidence used in the study
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5.2%‐8.4%) for colon cancer, 6.9% (95%CI 5.3%‐8.4%) for 
breast cancer, 7.7% (95%CI 6.2%‐9.0%) for hypertension, 
and 10.5% (95%CI 7.9%‐13.2%) for osteoporosis.
Based on the estimated PAFs for the above‐men-
tioned diseases, medical costs caused by physical inactiv-
ity in Switzerland in 2013 were estimated at 0.802 (95%CI 
0.684‐0.934) billion Swiss francs or at 1.2% (95%CI 
1.0%‐1.3%) of total health care expenditures. This is equiv-
alent to 116 (95%CI 99‐135) Swiss francs per capita. Of 
these medical costs, 35.4% were attributed to cardiovascular 
diseases (coronary heart disease, stroke, and hypertension), 
20.9% to back pain, 17.5% to depression, and the remain-
ing 26.2% to osteoporosis, diabetes type 2, colon cancer, 
and breast cancer (Table 2). Productivity losses were valued 
at 0.808 (95%CI 0.653‐0.983) billion Swiss francs or 117 
(95%CI 94‐142) Swiss francs per capita and were mainly 
caused by back pain (38.2%), depression (20.0%), and car-
diovascular diseases (17.9%).
We estimated the DALYs lost due to physical inactivity 
at 40 433 DALYs (95%CI 34 935‐46 487) or at 2.0% (95%CI 
1.7%‐2.2%) of total DALYs lost in Switzerland in 2013. 
Osteoporosis contributed 34.4% of the total DALYs, back pain 
17.7%, cardiovascular diseases 21.9%, and depression 8.3%.
In the scenario analysis 1, in which we applied a different 
PAF formula (formula (1)), the medical costs due to physi-
cal inactivity in Switzerland in 2013 were estimated at 0.837 
billion Swiss francs or at 1.2% of total health care expen-
ditures. Productivity losses were estimated at 0.840 billion 
Swiss francs and the DALYs lost due to physical inactivity 
at 44 932 DALYs (Table 3). These results are 4.0% (produc-
tivity losses) to 4.4% (medical costs) higher compared to the 
base case analysis.
3.2 | Burden of physical inactivity in the 
three language regions
In the German‐speaking region (68.6% of the Swiss popula-
tion), the prevalence of physical inactivity is 23.6%; in the 
French‐speaking region (24.8% of the population), the preva-
lence is 37.0%; and in the Italian‐speaking region (6.7% of 
Disease
Medical costs 
(million Swiss francs)
Productivity losses 
(million Swiss francs) DALYs
Hypertension 48 (38‐61) 4 (3‐5) 318 (248‐402)
Coronary heart 
disease
138 (72‐209) 93 (48‐143) 6108 (3255‐8771)
Stroke 98 (61‐143) 47 (29‐68) 2416 (1525‐3350)
Diabetes type 2 51 (33‐72) 72 (46‐102) 2652 (1733‐3694)
Breast cancer 32 (24‐40) 75 (57‐96) 2283 (1874‐2740)
Colon cancer 69 (53‐89) 46 (35‐60) 2237 (1877‐2641)
Osteoporosis 58 (44‐75) ‐ 13 913 (10 910‐17 554)
Back pain 167 (100‐248) 309 (179‐459) 7142 (4207‐10684)
Depression 141 (93‐196) 162 (106‐227) 3364 (2128‐4973)
Sum 802 (684‐934) 808 (653‐983) 40 433 (34 935‐46 487)
T A B L E  2  Medical costs, productivity 
losses, and DALYs due to physical 
inactivity in Switzerland in 2013 (95%CI)
Disease
Medical costs (million 
Swiss francs)
Productivity losses 
(million Swiss francs) DALYs
Hypertension 57 5 373
Coronary heart 
disease
133 90 5916
Stroke 83 40 2049
Diabetes type 2 50 70 2605
Breast cancer 38 91 2745
Colon cancer 83 55 2677
Osteoporosis 73 ‐ 17 659
Back pain 173 320 7402
Depression 146 169 3505
Sum 837 840 44 932
T A B L E  3  Results of sensitivity 
analysis using scenario 1
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the population), the prevalence is 39.1%. Due to these dif-
ferences in the prevalence of physical inactivity, language 
region‐specific PAFs were highest in the Italian‐speaking 
region, followed by the French‐speaking region and the 
German‐speaking region (Figure 2). In addition, most of the 
diseases for which physical inactivity is a recognized risk 
factor have a higher prevalence in the Italian‐ and French‐
speaking regions compared to the German‐speaking region 
(Supporting Information Section , Table S1). Per capita 
health care spending was 3523 Swiss francs in the French‐
speaking region, 3258 Swiss francs in the Italian‐speaking re-
gion, and 3174 Swiss francs in the German‐speaking region. 
Finally, the median monthly gross salary was 6481 Swiss 
francs in the German‐speaking region, 6419 Swiss francs 
in the French‐speaking region, and 5437 Swiss francs in the 
Italian‐speaking region.
We estimated per capita medical costs due to physical in-
activity in the German‐speaking region in 2013 at 87 Swiss 
francs, productivity losses at 96 Swiss francs, and DALYs 
per 1000 persons at 4.5. Medical costs in the French‐speaking 
region were estimated at 179 Swiss francs per capita, produc-
tivity losses at 164 Swiss francs, and DALYs at 8.9 per 1000 
persons. In the Italian‐speaking region, per capita medical 
costs were valued at 172 Swiss francs, productivity losses 
at 153 Swiss francs, and DALYs at 8.6. Figure 3 shows the 
relative contribution of each language region to the national 
burden of physical inactivity in 2013.
In the scenario analysis 2, in which we assumed that the 
only difference between the language regions would be the 
prevalence of physical inactivity, the German‐speaking re-
gion contributed to 57.9% of the national burden due to phys-
ical inactivity, while the French‐speaking region contributed 
32.8% and the Italian‐speaking region 9.4%. Compared to 
the base case analysis, the per capita medical costs due to 
physical inactivity were overestimated by 7% in the German‐
speaking region and underestimated by 18% in the French‐
speaking region and by 10% in the Italian‐speaking region.
4 |  DISCUSSION
This study estimated the burden of physical inactivity at 1.610 
(95%CI 1.413‐1.827) billion Swiss francs plus 40433 (95%CI 
34 935‐46 487) DALYs in Switzerland in 2013. Low back 
pain and depression, two diseases not included in most previ-
ous studies investigating the burden of physical inactivity, 
F I G U R E  2  Estimated PAFs for physical inactivity for each language region in Switzerland
F I G U R E  3  Contribution of each language region to the national burden of physical inactivity
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added substantially to the results. Furthermore, the analysis 
of regional differences revealed that the per capita burden of 
physical inactivity is about twice as high in the French‐ and 
Italian‐speaking regions compared to the German‐speaking 
region.
Our results correspond to previous findings from interna-
tional studies. 0.6% (95%CI 0.4%‐0.7%) of health care costs 
could be attributed to physical inactivity in Switzerland in 
2013 when only considering coronary heart disease, stroke, 
diabetes type 2, breast cancer, and colon cancer. Based on 
the same set of diseases, Ding et al6 reported a proportion of 
0.6% (95%CI 0.1%‐2.2%) for Germany (prevalence of physi-
cal inactivity: 21.1%), of 0.4% (95%CI 0.1%‐0.9%) for France 
(prevalence: 23.4%), and of 0.5% (95%CI 0.1%‐1.8%) for 
Italy (prevalence: 33.2%). Our findings are thus in line with 
these results for the neighboring countries of Switzerland. 
Previous international studies estimated proportions between 
1.0% and 3.8%.11,25,26 Our results are somewhat lower due 
to the lower prevalence of physical inactivity in Switzerland 
and, as showed in the first scenario analysis, due to the more 
conservative PAF formula used in our study.27
Only a small number of previous studies included produc-
tivity losses in their analysis of the economic burden of physi-
cal inactivity and due to different methodological approaches, 
the results of these studies differ widely. Productivity losses 
four times smaller than the medical costs were reported in 
one study that used a friction cost approach.6 Two other 
studies used a human capital approach.11,28 They estimated 
productivity losses in the amount of the medical costs and 
twice the amount of the medical costs, respectively. We also 
used a human capital approach in our study and estimated 
productivity losses in the amount of the medical costs. A re-
cent study estimated that physical inactivity is responsible 
for approximately 1.5% of global DALYs.29 When consid-
ering similar diseases, we estimated the proportion at 0.8% 
(95%CI 0.6%‐0.9%). Our lower proportion of 0.8% is mainly 
due to a relatively low prevalence of physical inactivity in 
Switzerland.
The findings of our study are also comparable to the re-
sults reported by Martin et al7 who estimated total costs due 
to physical inactivity in Switzerland in 2000 at 2.384 billion 
Swiss francs, 48% higher than our estimation for 2013 (med-
ical costs: 1.579 billion Swiss francs, 96.8% higher than our 
estimation; productivity losses: 0.805 billion Swiss francs, 
0.4% lower than our estimation). In comparison with this 
study, we considered similar diseases, but used up to date 
medical costs, productivity losses, and RR estimates. As 
shown in the first scenario analysis, we also used a more 
conservative PAF formula. When comparing these two stud-
ies, it should also be considered that self‐reported physical 
activity behavior changed in Switzerland in recent years. In 
2002, 37% of the Swiss population reported to be physically 
inactive, whereas this proportion decreased to 28% in 2012.2
To the best of our knowledge, this is the first study that 
investigated the economic burden of physical inactivity in 
the three language regions of Switzerland. Although a small 
country, Switzerland is an interesting case for analyzing the 
influence of regional cultural differences. Cultural differ-
ences often refer to differences in habits and beliefs. There 
is evidence for different health habits and believes between 
Swiss language regions. Bringolf et al3 showed that the en-
vironment for physical activity is more favorable, and the 
socioeconomic status is higher in the German‐speaking re-
gion compared to the French‐speaking region. In their study, 
however, language region was a strong correlate of physical 
activity independent of individual, social, and environmental 
factors. Interestingly, differences between language regions 
were found also for other health behaviors than physical ac-
tivity. Faeh et al30 showed that smoking and daily alcohol 
consumption were less frequent in the German‐speaking re-
gion compared to the French‐speaking region. Furthermore, 
cause‐specific mortality substantially differed between lan-
guage regions although all‐cause mortality did not differ. 
Another study investigated Swiss adolescents and showed 
that self‐reported low physical fitness is more frequent in 
the French‐speaking region than in the German‐ and Italian‐
speaking regions.31 In contrast, unfavorable self‐rated health 
was less frequent in the French‐speaking region than in the 
German‐ and Italian‐speaking regions.
We found that the French‐ and Italian‐speaking regions, 
which are home to 30% of the Swiss population, contribute 
more than 45% to the burden of physical inactivity. Reasons 
include a higher prevalence of physical inactivity, higher 
per capita health care spending, and higher disease preva-
lence than the German‐speaking region. However, higher 
disease prevalence in the French‐ and Italian‐speaking re-
gions might be due to regional differences in screening and 
management.32 Underdiagnosis of diseases in the German‐
speaking region could thus have led to an overestimation 
of regional differences. The second scenario analysis, in 
which we assumed that the only difference between the 
language regions would be the prevalence of physical in-
activity, changed the results by 10%. Therefore, as many 
relevant aspects as possible should be considered when 
comparing different regions. Our PAFs for the German‐ and 
Italian‐speaking regions also correspond very well with the 
PAFs for Germany and Italy from a recent study.6 Due to 
differences in the prevalence of physical inactivity (French‐
speaking region of Switzerland 37.0%, France 23.4%), our 
PAFs for the French‐speaking region are approximately 2% 
(absolute) higher compared to the PAFs for France from 
the same study. These observations support the plausibility 
of our estimates of regional differences. They also indicate 
that the propensity score matching using Swiss data led to 
estimates of the prevalence of physical inactivity in cases 
eventually developing the disease similar to those reported 
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in a recent study investigating the burden of physical inac-
tivity on a global level.6
Strengths of our study are the variety of diseases and 
outcomes (DALYs, medical costs, and productivity losses) 
considered. Furthermore, the data source for the medical 
costs addressed a frequent criticism of cost of illness studies, 
namely that the sum of the cost estimates for single diseases 
may exceed the aggregate total cost of health care. As Wieser 
et al9 decomposed total Swiss health care costs to diseases, 
double counting of medical costs is not an issue in our study. 
The GBD study does also adjust the YLD for comorbidities 
to address potential overestimation of total health loss. In ad-
dition, we were able to estimate country‐specific correction 
factors to approximate the prevalence of physical inactivity 
in cases eventually developing the disease by applying pro-
pensity score matching to data from the Swiss Health Survey. 
This allowed us to use the recommended PAF formula for 
physical inactivity.6,24,33
The main limitation of our study is the uncertainty aris-
ing from the use of secondary data sources. For example, 
the RR we used for our calculations are not based on a 
standardized definition and measurement of physical ac-
tivity and a standardized assessment of confounding. We 
also assumed equal RR across gender and age‐groups. 
Although we used RR maximally adjusted for confounding 
and included relevant risky health behaviors such as smok-
ing and alcohol use in the propensity score matching, we 
cannot preclude that residual joint effects of risky health 
behaviors may have influenced our results.34 In addition, 
there may be other diseases for which physical inactivity 
will be established as a risk factor. For example, a recent 
study reported a PAF for physical inactivity and demen-
tia in Europe of 3.7% (95%CI 1.5%‐6.9%).33 However, we 
were not able to include this disease in our analysis due 
to limited data availability for Switzerland. Obesity is not 
included as a specific primary disease; however, it is re-
flected in the secondary cardiovascular and metabolic dis-
eases. A further limitation is that response in the Swiss 
Health Survey was non‐random. For instance, responders 
were of higher average socioeconomic status and reported 
better subjective health than non‐responders.35 This may 
have affected our estimates of the burden of physical inac-
tivity. Furthermore, we may have underestimated the prev-
alence of physical inactivity as the Swiss Health Survey 
investigates self‐reported activity levels. A recent study 
from Switzerland reported that time spent physically active 
was 4.2 times higher according to self‐reported question-
naires than measured with accelerometers.36 Several other 
studies also showed substantial differences between self‐
reported physical activity and objective measurements.37 
The available RR estimates are also based on self‐reported 
activity levels. Assuming a decreasing risk of disease for 
increasing physical activity, we would expect higher RR 
based on accelerometer measurements than based on self‐
reporting.38 Our effect estimates are consistent in the sense 
that both prevalence and RR were based on self‐reported 
physical activity levels, but we would still expect higher 
PAFs and consequently a higher estimated burden if physi-
cal activity was measured objectively with accelerometers. 
It is also noteworthy that we only investigated the impact of 
physical activity on primary prevention. There are several 
diseases in which physical activity is an effective modifier 
of the course of clinical disease, and one could argue that 
there is an additional burden related to inactive patients. 
Furthermore, we did not include home‐based and leisure‐
based production losses in our analysis. Finally, we did not 
consider costs of myocardial infarctions occurring during 
physical activity and costs of sport injuries. However, there 
is evidence that sport injuries especially happen to people 
that are not regularly active.39
5 |  PERSPECTIVES
This study shows that low back pain and depression substan-
tially add to the burden of physical inactivity. Consequently, 
future studies should consider these two diseases when es-
timating the burden of physical inactivity. Policy makers 
aiming at assessing the regional burden of physical inactivity 
should consider not only the regional prevalence of physi-
cal inactivity but also regional disease prevalence and health 
care spending.
In regard to Switzerland, this study shows that physical 
inactivity causes a substantial disease burden in Swiss adults 
and that the French‐ and Italian‐speaking regions are over‐
proportionally affected. Investments in interventions aiming 
to increase physical activity should therefore be considered. 
Research is needed to identify effective interventions to 
promote physical activity in the different language regions. 
Furthermore, we recommend the consideration of regional 
differences when assessing the cost‐effectiveness of such in-
terventions, as regional differences may have consequences 
for the optimal resource allocation in physical activity pro-
motion policies. This latter aspect may not only be relevant 
for Switzerland but also for other multicultural countries and 
other health promotion settings.
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Supporting information 
Section 1: Estimation of productivity losses for hypertension 
For hypertension, we used the Cause of Death Statistic1 provided by the Swiss Federal 
Statistical Office to estimate the costs due to death before the statutory retirement age. 
Future losses due to premature mortality were discounted to present value at a 2% discount 
rate. This interest rate corresponded to the interest rate of long-term bonds from the Swiss 
government in the last 20 years.2 Information regarding age group- and gender-specific labor 
market participation and average weekly workload stem from the Swiss Labor Force Survey3 
and were used in order to account for early retirement and reduction of employment. 
Furthermore, we used age group- and gender-specific median wages from the Swiss 
Earnings Structure Survey.4 A proportion of 10% was added to these wages to account for 
employers' contributions to the mandatory Swiss pension scheme. Wages were extrapolated 
to the year 2013 according to the nominal wage increase. 
 
 
 
Section 2: Estimation of burden per language region 
The prevalent disease cases (Table S1) were estimated from the data of the 2012 Swiss 
Health Survey5 to calculate the burden per case (Table S2). We used survey weights 
provided by the Swiss Federal Statistical Office to estimate results representative for the 
Swiss population older than 15 years. In this survey, respondents were asked whether they 
currently were or had ever been in medical treatment for a number of specific diseases. If 
respondents had not been in medical treatment in the past 12 months, they were asked if 
they still suffered from the disease. In addition, respondents reported drug use related to a 
number of specific diseases in the past seven days. We did not consider drug use to 
estimate the prevalence of osteoporosis, since the relevant medications are often used for 
prevention. Furthermore, we were not able to distinguish diabetes type 2 from type 1 in the 
Swiss Health Survey, i.e. the prevalence of diabetes represents the prevalence of diabetes 
type 1 and type 2. The Swiss Health Survey also investigated cancer without differentiating 
between specific types of cancer. In consequence, this information on total cancer 
prevalence was only used to model differences between the language regions. To estimate 
the prevalence of breast cancer and colon cancer, data from the National Institute for Cancer 
Epidemiology and Registration (NICER)6,7 were used.  
TABLE S1 Prevalence of the diseases for which physical inactivity is a recognized risk factor per 
Swiss language region in 2013  
  German-speaking French-speaking Italian-speaking 
  N % N % N % 
Population size 4753973 100% 1716268 100% 463763 100% 
Hypertension 923085 19% 312011 18% 101743 22% 
Coronary Heart Disease 305232 6% 150325 9% 45497 10% 
Stroke 49244 1% 26603 2% 4094 1% 
Diabetes Type 2 208368 4% 85054 5% 25136 5% 
Breast cancer 15575 0.3% 6725 0.4% 1493 0.3% 
Colon cancer 8766 0.2% 3785 0.2% 840 0.2% 
Osteoporosis 138611 3% 74038 4% 15493 3% 
Back pain 330372 7% 115810 7% 34862 8% 
Depression 354695 7% 133353 8% 42694 9% 
 
 
 
 
TABLE S2 Direct medical costs, productivity losses and DALYs per case per year in Switzerland in 
2013 
Disease Direct medical costs (Swiss francs) 
Productivity losses 
(Swiss francs) DALYs 
Hypertension 463 43 0.003 
Coronary Heart Disease 5916 4133 0.267 
Stroke 21174 10371 0.530 
Diabetes Type 2 2907 4172 0.153 
Breast Cancer 18503 45212 1.354 
Colon Cancer 73613 50498 2.412 
Osteoporosis 2241 - 0.549 
Back Pain 8368 15756 0.360 
Depression 5132 6053 0.124 
 
 
 
 
Section 3: Prevalence of physical inactivity 
Respondents from the Swiss Health Survey suffering from a disease for which physical 
inactivity is a recognized risk factor were matched with respondents not suffering from this 
disease by propensity score matching.8 A propensity score was calculated for each 
participant using a logit regression model. The propensity score was defined as the 
participant’s conditional probability of being exposed to a specific disease given the observed 
covariates. Covariates included were: behavior (smoking, alcohol use, eating habits, 
lifestyle), personal characteristics (sex, bmi, education) and environmental factors (stress at 
work, language region, urban/rural). Two participants with a similar propensity score had an 
equal estimated probability of having the disease. The participants were matched using a 
kernel matching algorithm.9 Common support was guaranteed by minima and maxima 
comparison.10 The propensity score matching was implemented without distinguishing 
between language regions. The prevalence of physical inactivity in the matched participants 
without the specific disease was divided by the prevalence of physical inactivity in the total 
Swiss population to estimate disease specific correction factors (Table S3). Corresponding 
95% confidence intervals (CI) were estimated based on the Clopper-Pearson method. The 
correction factors were then multiplied with the physical inactivity levels of each language 
region, thus estimating the prevalence of physical inactivity in the cases eventually 
developing the disease. Stata, version 14.2 (StataCorp, College Station, Texas, USA) was 
used for propensity score matching. 
 
 
TABLE S3 Correction factors resulting from the propensity score matching and correction factors 
reported in previous studies 
Disease Value 
95% CI 
lower 
bound 
95% CI 
higher 
bound 
Range from 
literature 
Source (given range 
only includes European 
studies) 
Hypertension 1.05 1.00 1.11 not available   
Coronary Heart Disease 1.14 1.05 1.23 1.13 - 1.34 Lee et al.11 
Stroke 1.32 1.08 1.56 1.21 - 1.47 Ding et al.12 
Diabetes Type 2 1.15 1.04 1.27 1.20 - 1.31 Lee et al.11 
Breast Cancer 1.01 0.87 1.16 0.77 - 1.11 Lee et al.11 
Colon Cancer 1.01 0.87 1.16 1.17 - 1.54 Lee et al.11 
Osteoporosis 1.05 0.92 1.20 not available   
Back Pain 1.07 0.97 1.17 not available   
Depression 1.09 1.00 1.18 not available   
 
 
 
 
References 
1. Federal Statistical Office. Cause of Death Statistics 2011. Neuchatel, Switzerland2013. 
2. Wieser S, Ruthemann I, De Boni S, et al. Cost of acute coronary syndrome in 
Switzerland in 2008. Swiss medical weekly. 2012;142:w13655. 
3. Federal Statistical Office. Swiss Labor Force Survey 2012. Neuchatel, Switzerland2014. 
4. Federal Statistical Office. Swiss Earnings Structure Survey 2012. Neuchatel, 
Switzerland2014. 
5. Federal Statistical Office. Swiss Health Survey 2012. Neuchatel, Switzerland2013. 
6. Foundation National Institute for Cancer Epidemiology and Registration (NICER). 
Prevalence of breast cancer in Switzerland. Zurich, Switzerland2014. 
7. Foundation National Institute for Cancer Epidemiology and Registration (NICER). 
Prevalence of cancer of colon and rectum in Switzerland. Zurich, Switzerland2014. 
8. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational 
studies for causal effects. Biometrika. 1983;70(1):41-55. 
9. Heckman JJ, Ichimura H, Todd P. Matching as an econometric evaluation estimator. 
Review of Economic Studies. 1998;65:261-294. 
10. Lechner M. Some practical issues in the evaluation of heterogeneous labour market 
programmes by matching methods. Journal of the Royal Statistical Society: Series A. 
2002;165(1):59-82. 
11. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical 
inactivity on major non-communicable diseases worldwide: an analysis of burden of 
disease and life expectancy. Lancet. 2012;380(9838):219-229. 
12. Ding D, Lawson KD, Kolbe-Alexander TL, et al. The economic burden of physical 
inactivity: a global analysis of major non-communicable diseases. Lancet. 
2016;388(10051):1311-1324. 
 
38 
 Publication 2: Physical activity interventions for primary 
prevention in adults: a systematic review of randomized 
controlled trial‑based economic evaluations 
 
Authors: 
Renato Mattli1,2 
Renato Farcher2 
Maria-Eleni Syleouni2 
Simon Wieser2 
Nicole Probst-Hensch3,4 
Arno Schmidt-Trucksäss5 
Matthias Schwenkglenks1 
1Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland 
2Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, 
Switzerland 
3Swiss Tropical and Public Health Institute, Basel, Switzerland 
4University of Basel, Basel, Switzerland 
5Division of Sports and Exercise Medicine, University of Basel, Basel, Switzerland 
 
Published in: 
Sports Med. 2020;50:731–750 
doi: 10.1007/s40279-019-01233-3 
 
The final publication is available at: 
https://link.springer.com/article/10.1007%2Fs40279-019-01233-3 
 
Reprinted by permission from Springer Nature Switzerland AG 
 
 
Abstract 
Background: Physical inactivity is a worldwide pandemic associated with major chronic 
diseases. Given limited resources, policy makers are in need of physical activity interventions 
that provide best value for money. 
Objective: To summarize evidence from RCT-based economic evaluations of primary 
prevention physical activity interventions in adult populations outside the workplace setting. 
Design: Systematic review of health economic evaluations. Incremental cost-effectiveness 
ratios (ICERs) in US$ per MET-hour gained were estimated on the basis of mean differences 
in intervention costs and standardized effects between intervention and control groups. 
Data sources: Identification of relevant studies via systematic searches in electronic 
databases (MEDLINE, Embase and NHSEED). 
Eligibility criteria: Cost-effectiveness analyses in which all data (except unit costs) came 
from one RCT investigating physical activity interventions for primary prevention or health 
promotion in an adult population in high-income countries.  
Results: In twelve eligible studies, 22 interventions were investigated. Interventions were 
based on advice, goal setting and follow-up support, exercise classes, financial incentives or 
teaching on behavioral change. The ICER varied widely among the interventions and four 
interventions showed an ICER below the applied benchmark of US$0.44 to US$0.63 per 
MET-hour gained. These four interventions were based on individualized advice via print or 
web. 
Conclusion: We found evidence from RCTs indicating cost-effectiveness of some physical 
activity interventions for primary prevention in adults. However, the majority of interventions 
assessed would not be cost-effective according to the benchmark applied. Furthermore, our 
study showed that trial-based evidence on cost-effectiveness of physical activity 
interventions is scarce. Therefore, we recommend that future studies investigating the 
 
 
efficacy or effectiveness of such interventions consider costs as an additional outcome and 
assess cost-effectiveness. 
 
Key points 
• We found evidence from RCTs indicating cost-effectiveness of some physical activity 
interventions for primary prevention in adults. However, cost-effectiveness results 
varied widely among interventions. Four interventions that delivered individualized 
advice via print or web showed best value (physical activity gains) for money 
(intervention costs). 
• Our study shows that trial-based evidence on cost-effectiveness of physical activity 
interventions is relatively scarce. 
• We recommend that future studies investigating the efficacy or effectiveness of 
interventions aimed at increasing physical activity consider costs as an additional 
outcome and assess cost-effectiveness. 
 
 
1 Introduction 
Physical inactivity is a worldwide pandemic that causes substantial health and economic 
burden [1-3]. Established health consequences of physical inactivity include cardiovascular 
diseases, diabetes and different types of cancer [3]. However, there is growing evidence that 
physical inactivity is also related to musculoskeletal and mental health problems [4-6], which 
has not been explored in the majority of studies. This may result in an underestimation of the 
true burden of physical inactivity. The substantial burden of physical inactivity calls for 
interventions aiming to increase physical activity. 
With limited resources available, policy makers are interested in interventions that provide 
best value for money. Therefore, interventions aiming to reduce physical inactivity should not 
only prove effectiveness on health outcomes but also cost-effectiveness. Economic 
evaluation studies compare costs and outcomes of an intervention with a comparator. In the 
area of physical activity, the comparator is often doing nothing, non-physical activity related 
advice or standard physical activity advice [7]. 
There are two different approaches in economic evaluations: trial-based economic 
evaluations and model-based economic evaluations [8]. In a trial-based economic evaluation, 
costs are measured within a randomized controlled trial (RCT) investigating the effect of the 
intervention [9]. In a model-based economic evaluation, data on the effect and the costs from 
different sources are combined in a decision-analytic model [10]. Both methodological 
approaches have strengths and weaknesses [9-11]. The main strengths of a trial-based 
economic evaluation are related to the methodological strength of RCTs, i.e. the exclusion of 
potential biasing factors [12]. However, RCTs have weaknesses when directly used for policy 
making that are related to the efficacy versus effectiveness discussion [12]: Areas of 
potential concern include choice of comparator, protocol-driven costs and outcomes, artificial 
environment, intermediate versus final outcomes, inadequate participant follow-up, and 
selected patient and provider populations [12]. Model-based economic evaluations have the 
strength that they can synthesize the best evidence available in case relevant head-to-head 
 
 
clinical trials are missing, costs were not measured within trials, intermediate endpoints were 
captured or trial follow-up was short-term [8]. Nevertheless, inappropriate use of clinical data, 
bias in observational data, difficulties of extrapolation and concerns about transparency or 
validity of models are major concerns [8]. These strengths and weaknesses make it evident 
that for policy making reasons the two methods are better used complementarily than 
alternatively [13]. In any case, the review of available evidence, e.g. trial-based economic 
evaluations, remains a prerequisite for conducting model-based economic evaluations. 
Several systematic reviews have investigated the cost-effectiveness of physical activity 
interventions but most of these reviews focused on specific settings (e.g. school, workplace, 
community) and did not pay much attention to the methodological approaches (trial-based or 
model-based) chosen in the identified economic evaluations [14]. The availability of trial-
based economic evaluations of physical activity interventions seems to be limited [7, 15-17], 
and to the best of our knowledge, no systematic review has focused on this topic. 
Consequently, this study aims to systematically review trial-based economic evaluations of 
interventions to reduce physical inactivity in the general adult population. 
 
 
2 Methods 
We conducted our study according to current recommendations for systematic reviews of 
health economic evaluations [18-20].  
2.1 Eligibility criteria 
We defined the following inclusion criteria: 
Population: General adult population (≥18 years) in high-income countries as defined 
according to the World Bank [21]. We focused on populations in which physical activity would 
be considered to be primary prevention or health promotion. Consequently, we excluded 
studies investigating physical activity as secondary or tertiary prevention in patients with 
diseases such as stroke, diabetes, obesity, COPD, multiple sclerosis or mental health issues. 
As we focused on interventions that can be implemented on a population-level, we excluded 
studies on specific populations such as worksite populations, students or soldiers. 
Intervention: Any intervention aimed to increase physical activity.  
Comparator: No intervention (doing nothing), non-physical activity related advice or any other 
intervention aimed to increase physical activity. 
Outcomes: Effectiveness (e.g. change in physical activity minutes, change in walking time, 
change in steps per day, change in the number of physically active individuals) and 
intervention costs. We excluded studies that did not report specific physical activity 
outcomes, e.g. studies only reporting quality-adjusted life-years as part of pure cost-utility 
analyses.   
Study design: Cost-effectiveness analyses in which all data (except unit costs) came from 
one RCT of any follow-up duration. Consequently, we excluded health economic modelling 
studies and cost-effectiveness analyses from trials with a design other than RCT. 
We focused on recently published studies since the year 2000 written in English or German. 
 
 
2.2 Search strategy 
We searched for studies using the following electronic databases: MEDLINE (via Pubmed), 
Embase and NHSEED. The search strategy was defined using the PRESS checklist [22]. As 
detailed in Table 1, we created a search string for physical activity and one for economic 
evaluations. These strings were then combined to identify economic evaluations of physical 
activity interventions. The search strategy was validated with the cost-effectiveness studies 
identified by Foster et al. [16]. The final search was conducted on 31 July 2019. 
Table 1 Detailed search strategy 
Concept 1 
physical activity 
Mesh/Emtree Search 
• Mesh (for Pubmed): Exercise [Mesh] (not one level higher (Motor Activity [Mesh]) as otherwise 
getting many animal studies); Physical Fitness [Mesh] 
• Emtree for Embase: Physical activity; Physical inactivity; Fitness 
Expressions from titles/abstracts used to describe physical activity – Keyword Search 
• physical activity OR physically active OR physical inactivity OR physically inactive OR physical 
fitness OR active lifestyle OR inactive lifestyle OR sedentary lifestyle OR sedentary behavior OR 
sedentary behaviour 
• biking OR bike* OR bicycling  
• walk* (only in title, otherwise too broad) OR pedestrian* OR running (only in title, otherwise too 
broad) OR jogging OR stair climbing OR climbing stairs 
• active travel* OR active commut* OR built environment OR environment* design OR 
environment* planning OR city planning OR urban planning 
Concept 2 
economic evaluations 
Mesh/Emtree Search 
• Mesh (for Pubmed): Cost-Benefit Analysis [Mesh] 
• Emtree for Embase: Cost effectiveness analysis; Cost benefit analysis; Cost utility analysis 
Expressions from titles/abstracts used to describe cost-effectiveness – Keyword Search 
• economic analy* OR economic evaluation OR economic assess* 
• cost-effective* OR cost-benefit* OR cost-utility OR benefit-cost OR cost-effica* 
 
2.3 Study selection 
Identified studies were exported into Endnote and duplicates were removed. Prior to the 
screening of the identified studies, training sessions took place to ensure high consistency 
between reviewers. Afterwards, two reviewers (RM, RF) screened all studies separately. 
Title/abstracts were screened first, followed by a full-text screening. Disagreements between 
reviewers after screening title/abstracts and the assessment of full-text were resolved by 
consensus. Unclear cases were discussed with a third reviewer (MS).  
2.4 Data extraction 
We extracted data on the study design including random sequence generation, allocation 
concealment and blinding. Furthermore, we collected information regarding the definition of 
 
 
the study population, details about the intervention and control groups, outcome definition 
and measurement, and results. A data extraction form was created in Microsoft Excel, pilot 
tested independently by two reviewers and subsequently adapted to ensure all relevant data 
being captured. Data were then extracted by one reviewer and confirmed by a second 
reviewer. Disagreements were again resolved by consensus. In case required information 
was not reported in the publication, data were extracted from additional publications relating 
to the same study, e.g. study protocols.  
2.5 Risk of bias and quality assessment 
Risk of bias was assessed using the criteria from the Cochrane risk of bias tool and the 
consensus on health economics criteria (CHEC) list [23, 24]. Two reviewers evaluated the 
selected studies independently and any disagreement was again resolved by consensus. As 
in previous systematic reviews of interventions promoting physical activity, we did not rate 
studies on whether participants were blinded to their allocation to intervention or control 
groups [7], because it would be impossible to blind participants to a physical activity 
intervention. For the assessment of the performance bias, we therefore considered blinding 
of the personnel and if this may have affected the outcome. If publications from the same 
study were referenced, we also checked these additional references for information 
supporting the risk of bias assessment.  
2.6 Data synthesis 
The studies included in the review reported different physical activity outcomes. In order to 
compare the results between studies, effect measures were standardized. The standardized 
effect measure was the metabolic equivalent of task (MET) measured in MET-hours gained 
per person per day. One MET is defined as the resting energy expenditure, which is 
equivalent to an oxygen consumption of 3.5 ml/kg/min. The MET of an activity is a 
multiplicator of the resting energy expenditure and represents the intensity of an activity. To 
calculate the volume of physical activity we multiplied frequency by duration of physical 
activity as MET-hours. The formula by Wu et al. [17] was used to translate physical activity 
 
 
outcomes to MET-hours gained per person per day. For these calculations, 3.0 METs were 
assigned to moderate physical activity, 4.5 METs to moderate-to-vigorous physical activity 
and 6.0 METs to vigorous physical activity [17]. We choose these relatively low values to be 
consistent with other studies in the field [17, 25] and because of the well-documented large 
overestimation of physical activity intensity by self-report [26-28]. Whenever possible, the 
results of a twelve-month follow-up interval were taken to make the studies comparable. 
Physical activity interventions cause different types of costs, e.g. intervention costs, costs to 
participants, healthcare costs or production losses [29]. We therefore extracted the costs 
separately for each type. Cost types included in all studies (i.e. intervention costs) were used 
to compare costs between studies. The costs were converted to US dollars (US$) using 
purchasing power parity conversion factors for the reference year [30]. Costs were then 
extrapolated to the year 2018 using the total consumer price index for the US [31]. 
We further calculated the mean differences in costs and outcomes between intervention and 
control as a basis for estimating the incremental cost-effectiveness ratio (ICER) in US$ per 
MET-hour gained. The outcome in MET-hours per person per day was multiplied with the 
number of days of follow-up to make the outcome comparable to the costs and, therefore, 
allow us to compare interventions with different follow-up times. Wu et al. [17] used a 
benchmark of US$0.50 to US$1.00 per MET-hour gained to assess cost-effectiveness of 
physical activity interventions. This benchmark is based on the per capita health care costs 
of physical inactivity in the US and the recommendation for health‐enhancing physical activity 
by the WHO [32]. This means at least 2.5 hours per week of physical activity with moderate 
intensity or 1.25 hours per week of physical activity with vigorous intensity [32]. We used the 
same approach as Wu et al. [17] but applied current health care costs and productivity losses 
of physical inactivity in Switzerland [33]. Based on the lower and upper bound of the 95% 
uncertainty interval reported, we estimated a benchmark between US$0.44 and US$0.63 per 
MET-hour gained [33]. Swiss health care costs were extrapolated from 2013 to 2018 
 
 
according to the increase in per capita health care spending and productivity losses were 
extrapolated using the wage index [34, 35]. 
 
 
3 Results 
3.1 Study identification 
Our searches retrieved 5060 potentially relevant studies (Fig. 1). After removing 1288 
duplicates, 3772 title/abstracts were screened. Many studies had to be excluded as they 
investigated populations not matching our inclusion criteria or the study design was not an 
RCT. After screening of title and abstract, 36 full-text publications were assessed for 
eligibility. Of these 36 publications, 24 were excluded because the population was not 
fulfilling our inclusion criteria (10 publications), the physical activity (5 publications) or cost 
outcome (6 publications) was not reported in sufficient detail, the study was a model-based 
evaluation of an initial trial that was included in our analysis (1 publication), the study 
investigated a follow-up intervention after an initial physical activity intervention (1 
publication), the journal publication reported a study that was included in our analysis based 
on the earlier published and more detailed Health Technology Assessment report (1 
publication). Twelve studies were included in the final evaluation. 
3.2 Description of included studies 
Details of the twelve included studies are provided in Table 2. Three trial-based cost-
effectiveness analyses were conducted in New Zealand [36-38], three in the UK [39-41], 
three in the USA [42-44], two in the Netherlands [45, 46], and one in Australia [47]. Eight 
studies recruited the participants through GPs [36-41, 46, 47], three studies used different 
channels for advertisements [42-44] and one study recruited participants with invitation 
letters [45]. The mean age of participants in the twelve studies ranged from 45 years to 74 
years. Female participants were more frequent in all of the studies except for the Dutch study 
conducted by van Keulen et al. [46], in which 45% of the participants were female. Four 
studies were clustered RCTs [37, 39, 40, 45]. In three studies, the trial arms had less than 
100 participants [42, 44, 47]. All the other studies had more than 100 participants per arm. 
 
 
 
Table 2 Overview on included studies 
Reference Country Populationa Interventionb Controlc Follow-upd Effect measures Cost measures 
Harris et al. 
[39] 
UK Adults aged 45-74 years 
recruited by their GP by 
invitation letter, physically 
inactive, able to walk outside the 
home and no contraindications 
to increase moderate to vigorous 
physical activity 
Mean age (years): not reported; 
range: 45-74 
Males (%): (1) 37; (2) 37; (C) 34 
(1) pedometer, individual targets for step 
counts over a period of 12 weeks and 
dairy for daily step counts all provided by 
post (n=339) 
(2) pedometer, individual targets for step 
counts over a period of 12 weeks and 
dairy for daily step counts all provided by 
a nurse plus three individually tailored 
physical activity consultations by a nurse 
at week 1, 5 and 9 (n=346) 
Doing nothing: 
Participants were 
advised to continue 
their usual physical 
activity and were not 
offered the 12-week 
intervention 
12 months Weekly minutes of 
moderate to vigorous 
physical activity (in ≥ 10-
minute bouts) as 
measured with 7-day 
accelerometry with a 
belt at the hip 
NHS perspective 
2 types of costs: 
intervention costs (set-up 
costs and delivery costs), 
healthcare costs 
Ewald et al. 
[47] 
Australia Adults aged >18 years recruited 
by their GP, average daily step 
count lower than 7000 steps per 
week, many participants with 
inactivity-related health problems  
Mean age (years): 57 
Males (%): 30 
Physical activity behavior change 
counseling delivered in two ways: 
(1) five face-to-face visits with an 
exercise physiologist (n=68) 
(2) one face-to-face visit with an 
exercise physiologist, followed by four 
sessions delivered by phone (n=64) 
Standardized print 
brochure encouraging 
physical activity (n=71) 
12 months Step count for one week 
with pedometer 
Payer perspective 
Intervention costs 
Golsteijn et 
al. [45] 
Netherlands Adults aged >50 years recruited 
based on matched 
neighborhoods from municipal 
health council regions 
Mean age (years): (1) 63; (2) 64; 
(3) 62; (4) 61; (C) 64 
Males (%): (1) 46; (2) 45; (3) 52; 
(4) 51; (C) 50 
Computer-tailored physical activity 
advice at three time-points (2 weeks, 2 
months and 4 months after baseline) 
delivered as either print (mail) or web 
(website and email) and in either a basic 
form (standard advice) or with additional 
environmental components (e.g., 
walking and cycling routes and PA 
possibilities and initiatives in 
participants’ own neighborhood and 
home exercises): 
(1) print-delivered basic (n=439) 
(2) print-delivered environmental 
(n=435) 
(3) web-based basic (n=423) 
(4) web-based environmental (n=432) 
Doing nothing: 
Participants in the 
control group were 
invited to complete 4 
questionnaires about 
physical activity during 
the upcoming year and 
they were told that 
they would receive 
physical activity advice 
after one year as a 
reward for their 
cooperation (n=411) 
12 months MET-hours per week 
based on the Dutch 
SQUASH [48] 
Societal perspective 
Intervention costs (fixed 
and variable), healthcare 
costs, participant and 
family costs (buying sports 
equipment, paying 
membership fees,…), 
productivity losses 
 
 
Iliffe et al. 
[40] 
UK Adults aged ≥65 years recruited 
by their GP with stable medical 
conditions, living independently, 
walking independently both 
indoors and outdoors (with or 
without a walking aid and without 
help from another person)   
Mean age (years): 73 
Males (%): 38 
2 intervention arms: 
(1) class-based exercise: FaME 
program, weekly classes plus home 
exercises for 24 weeks and encouraged 
walking (n=387) 
(2) home-based exercise: OEP, home 
exercises supported by peer mentors for 
24 weeks and encouraged walking 
(n=411) 
Doing nothing: 
Participants in the 
control group were not 
offered either the OEP 
or FaME program, but 
were free to participate 
in any other exercise 
just as they would if 
they were not 
participating in the trial 
(n=458) 
12 months 
after the end 
of the 
intervention 
period 
Proportion reaching the 
recommended physical 
activity target of 150 
minutes of moderate to 
vigorous physical 
activity per week based 
on the CHAMPS 
questionnaire [49] 
NHS and participant 
perspective 
Setup and management of 
the intervention; hire of 
facilities; equipment; 
human resources; travel 
and phone expenses 
related to delivering the 
intervention; participants’ 
out-of-pocket expenses 
related to exercising (incl. 
FaME) 
Leung et al. 
[38] 
New 
Zealand 
(Auckland) 
Adults aged ≥65 years recruited 
by their GP from communities in 
Auckland, who did not achieve 
the recommended 150 minutes 
of at least moderate physical 
activity per week; 97% of 
participants were of New 
Zealand European ethnicity 
Mean age (years): 74 
Males (%): 46 
Face-to-face advice, step-related goal 
setting, followed by phone counseling: 
initial face-to-face advice on engaging in 
physical activity from GP including goal 
setting, followed up by 3 phone 
counseling sessions by trained physical 
activity counselors over 3 to 4 months. 
Goal setting based on steps and 
participants were encouraged to use 
their pedometer to monitor steps. Goals 
were handed to participants on a green 
prescription card (n=165) 
Face-to-face advice, 
time-related goal 
setting, followed by 
phone counseling: 
Participants in the 
control group received 
the same intervention 
as participants in the 
intervention group with 
the exception that 
counseling focused on 
accumulating physical 
activity around time-
related goals rather 
than step-related goals 
(n=165) 
12 months Minutes of weekly 
leisure walking 
assessed with the 
Auckland Heart Study 
Physical Activity 
Questionnaire [50] 
Public health care system 
and participant perspective 
Three categories: (i) 
Community care costs, 
which included GPs, 
nurses, physiotherapists, 
other allied health 
professionals, home help, 
and the cost of the 
pedometer. (ii) Exercise 
and community care costs, 
which included the prior 
category plus all personal 
sport and exercise 
equipment and physical 
activity costs. (iii) All costs, 
which included the prior 
category plus all hospital-
related costs such as 
specialist consultations, 
outpatient procedures and 
inpatient stays. (Costs of 
coordinating the GRx 
program and of phone 
counseling were excluded 
as these costs were 
common to both patient 
groups) 
 
 
Elley et al. 
[36] 
New 
Zealand 
Women aged 40-74 years 
recruited by their GP and not 
achieving 30 minutes of at least 
moderate-intensity exercise such 
as brisk walking on 5 days or 
more per week 
Mean age (years): 59 
Males (%): 0 
Face-to-face advice, goal setting and 
follow-up by a face-to-face meeting and 
phone counseling: 10 minutes of brief 
advice and a written exercise 
prescription given by a primary 
healthcare nurse, face-to-face follow-up 
at 6 months and phone support for 9 
months from an exercise facilitator. The 
recommended goal was at least 30 min 
of moderate-intensity physical activity 
five times per week (n=544) 
Doing nothing: 
Participants in the 
control group received 
usual care from GP 
(n=545) 
24 months Minutes of moderate or 
vigorous physical 
activity per week 
assessed with the NZ 
Physical Activity 
Questionnaire [51] 
Societal perspective 
Direct and indirect costs 
including program delivery 
costs, participant exercise 
costs, primary and 
secondary care costs, 
allied healthcare costs and 
productivity costs 
Van Keulen 
et al. [46] 
Netherlands Adults aged 45-70 years 
recruited by their GP who failed 
to meet at least two out of three 
Dutch public health guidelines 
(physical activity, fruit and 
vegetable consumption), 50% 
diagnosed as hypertensive  
Mean age (years): 57 
Males (%): 55 
3 intervention arms: 
(1) TPC: four printed, tailored letters (1. 
letter: 4 pages about physical activity, 2. 
and 4. letter: 5 pages about fruits and 
vegetables, 3. letter: 3 pages about 
physical activity) (n=405) 
(2) TMI: four phone calls, the order of 
the conversation topics in the first and 
third interviews could be chosen by 
participants (if PA was preferred in the 
first interview, fruit and vegetables 
consumption was discussed in the 
second and vice versa) (n=407) 
(3) Combined: two tailored print letters 
and two phone motivational interviews, 
the first letter and interview focused on 
physical activity, the second letter and 
interview on fruit and vegetables 
consumption (n=408) 
Doing nothing: 
Participants in the 
control group received 
one tailored letter after 
the last follow-up 
questionnaire (n=409) 
73 weeks 
(approx. 17 
months) 
Proportion reaching the 
recommended physical 
activity target of 150 
minutes of moderate to 
vigorous physical 
activity per week 
measured with the 
modified CHAMPS 
physical activity 
questionnaire [52] 
(added to this was the 
summary question of the 
SQUASH [48]) 
Payer and participant 
perspective 
Fixed and variable costs 
involved in implementing 
the intervention (e.g. 
printing and mailing letters 
for TPC, call charges for 
TMI) and the costs of the 
time invested by 
participants  
 
 
Finkelstein 
et al. [42] 
USA Adults aged ≥50 years recruited 
through advertisements in two 
free local newspapers and a free 
online website of classified ads, 
self-reported as healthy and 
sedentary (currently exercising 
for less than 2h per week and if 
exercising, engaging in walking 
as their primary form of exercise) 
Mean age (years): (I) 59; (C) 61 
Males (%): (I) 24; (C) 27 
Financial incentive: The intervention 
group was offered $50 for base 
participation in the study as well as a 
variable incentive payment depending 
on participants' aerobic minutes during 
each of the 4 weeks of the study: 
- $0 if averaging less than 15 aerobic 
minutes per day each week 
- $10 if averaging at least 15 and less 
than 25 aerobic minutes per day each 
week 
- $15 if averaging at least 25 and less 
than 40 aerobic minutes per day each 
week 
- $20 if averaging 40 or more aerobic 
minutes per day each week 
(n=21) 
Fixed financial 
incentive: The control 
group received a fixed 
payment of $75 for 
attending a 90-minute 
kickoff meeting, 
wearing a pedometer 
daily and returning all 
study materials (n=30) 
4 weeks Daily aerobic minutes 
measured with 
pedometers over 4 
weeks 
Payer perspective 
Only costs due to 
incentives were included in 
the study 
Sevick et al. 
[44] 
USA Adults aged 18-65 years 
recruited from the community 
using advertisements in the 
newspaper and in a local 
hospital; participants were 
considered as healthy but 
sedentary (< 90 minutes per 
week of at least moderate or 
vigorous physical activity) based 
on a phone call from a research 
assistant 
Mean age (years): 45 
Males (%): 18 
2 intervention arms. Participants in both 
arms mailed in physical activity logs and 
brief surveys each month, which were 
used to generate individualized 
feedback with the goal to increase 
physical activity. Feedback was 
communicated to participants either via 
mail or phone: 
(1) a phone-based, individualized 
motivationally-tailored feedback 
intervention (n=80) 
(2) a print-based, individualized 
motivationally-tailored feedback (n=81) 
Doing nothing: The 
participants in the 
control group received 
mailings unrelated to 
physical activity on the 
same schedule as 
phone and print 
participants, as well as 
a packet of health 
information at the 
beginning of the study 
(n=78) 
12 months Minutes of physical 
activity per week as 
assessed in a 7-day 
physical activity recall 
interview [53] 
Payer perspective 
Intervention costs 
including those costs that 
would be borne by and 
outcomes that would be 
relevant to a health plan or 
insurer offering the 
intervention as part of their 
covered services 
Isaacs et al. 
[41] 
UK Adults aged 40-74 years 
recruited from their GP, not 
currently physically active, with 
at least one cardiovascular risk 
factor but without pre-existing 
overt cardiovascular disease, 
uncontrolled hypertension, 
uncontrolled insulin-dependent 
diabetes, psychiatric conditions 
or physical disabilities that would 
prevent participation in an 
exercise class 
Mean age (years): 57 
Males (%): 33 
10-week physical activity program with 
advice on how to continue and financial 
incentive: 
(1) a 10-week program of supervised 
exercise classes, two to three times a 
week in a local leisure center (n=317) 
(2) a 10-week instructor-led walking 
program, two to three times a week 
(n=311) 
 
Both with provision for continuing 
exercise at the end of the program. This 
included advice on how to continue 
being active and a financial incentive (a 
book of 20 half-price tickets for the 
leisure center). No charge was made to 
attend any of the exercise sessions 
during the 10-week period 
Individualized advice: 
The advice-only 
control group received 
tailored advice and 
information on physical 
activity including 
information on local 
exercise facilities. After 
6 months the control 
group were re-
randomized to one of 
the other trial arms 
(n=315) 
12 months Minutes of moderate 
and/or vigorous activity 
per week as measured 
with a 7-day recall 
questionnaire [54] 
NHS and participant 
perspective 
3 types of costs: 
intervention costs 
(facilities, exercise 
trainers, administrative 
support), participants costs 
(time, travel, pay for 
childcare, equipment), 
healthcare costs 
 
 
Elley et al. 
[37] 
New 
Zealand 
Adults aged 40-79 years 
recruited by their GP, "less 
active" meaning those who were 
not achieving the recommended 
2.5 hours of at least moderate 
activity per week 
Mean age (years): (I) 57; (C) 59 
Males (%): (I) 33; (C) 34 
Face-to-face advice, goal setting and 
follow-up by phone counseling: The 
intervention was verbal advice to 
increase physical activity with exercise 
goals written on a green prescription 
card by the GP. The prescription was 
then faxed to exercise specialists in 
Sports Foundations who provided phone 
support on three occasions over the 
following three months to each 
intervention patient and sent written 
material including newsletters (n=451) 
Doing nothing: The 
control group received 
usual care that may 
have included some 
verbal advice about 
physical activity 
(n=427) 
12 months Minutes of leisure 
exercise per week as 
measured with a self-
administered 
questionnaire which 
prompts recall of 
physical activity over 
three months [50] 
Societal perspective 
Intervention costs; health 
funder costs; patient costs; 
productivity costs 
Sevick et al. 
[43] 
USA Adults aged 35-60 years 
recruited through mass media 
(print, radio, TV), word of mouth 
and recontacting volunteers from 
previous studies. Participants 
were sedentary but healthy 
(meaning no history of 
myocardial infarction, stroke, 
insulin-dependent diabetes 
mellitus, osteoporosis, or 
osteoarthritis) 
Mean age (years): (I) 46; (C) 46 
Males (%): (I) 50; (C) 49 
Lifestyle intervention: Teaching of 
behavior modification and cognitive-
behavior modification techniques for 
behavior change in small group 
meetings. During the 18-month tapered 
phase, all participants received a 
quarterly newsletter and a monthly 
calendar of activities. (n=121) 
Exercise prescription: 
Participants in the 
control group received 
typical exercise 
prescription as 
described by the 
American College of 
Sports Medicine, 
involving an exercise 
intensity of 50%–85% 
of maximal aerobic 
power and exercise of 
20 to 60 minutes 
duration at each 
session. During the 
18-month tapered 
phase, all participants 
received a quarterly 
newsletter and a 
monthly calendar of 
activities. (n=114) 
24 months Energy expenditure per 
day from physical 
activity using the 7-day 
Physical Activity Recall 
questionnaire [53] 
Payer perspective 
Intervention staff time, 
computerized tracking 
system, curriculum 
materials, printing and 
postage, facilities, health 
club memberships. 
Legend: Studies ordered by year of publication, CHAMPS = Community Healthy Activities Model Program For Seniors scale, FaME = Falls Management Exercise, OEP = Otago Exercise Program, 
SQUASH = Short Questionnaire to Assess Health Enhancing Physical Activity, TMI = Telephone Motivational Interviewing, TPC = Tailored Printed Communication 
a description of the population investigated including how the participants were recruited followed by mean age of the population and sex distribution, (I) refers to intervention group, (C) refers to control 
group, in case of more than one trial arm (1) refers to trial arm one, (2) refers to trial arm two and so on 
b description of the intervention including the number of participants (n), in case of more than one trial arm (1) refers to trial arm one, (2) refers to trial arm two and so on 
c description of the control group including the number of participants (n) 
d last follow-up time point 
 
 
 
Twenty-two interventions were analyzed in the twelve studies. The interventions investigated 
in eight studies were advice and goal setting conducted in different ways such as face-to-
face, by telephone, using printed material or web contact/communication with different kinds 
of follow-up support [36-39, 44-47]. Exercise classes were researched in two studies [40, 41]. 
One study investigated financial incentives [42] and one study examined teaching on 
behavioral change [43]. In seven studies, the control group did not receive any information 
regarding physical activity during the study period, unless it was part of usual care [36, 37, 
39, 40, 44-46]. The other five studies compared the intervention group to a control group that 
also received an intervention that aimed at increasing physical activity [38, 41-43, 47]. As an 
example, in one study the control group received mailings unrelated to physical activity 
compared to the intervention arm with participants, who received telephone-based or print-
based individually tailored feedback [44]. In another example, the control group received 
fixed financial incentives, and the intervention group received incentives based on the 
amount of physical activity [42].  
The duration of follow-up was one month in one study [42], twelve months in eight studies 
[37-41, 44, 45, 47], 17 months in one study [46] and 24 months in two studies [36, 43]. The 
effect on physical activity was measured with self-reported questionnaires in eight studies 
[36-38, 40, 41, 43, 45, 46]. Two studies used pedometers in addition to activity logs and 
questionnaires to measure the outcome [42, 47] and one study used face-to-face interviews 
[44]. One study measured physical activity objectively by accelerometry [39].  
Costs were assessed using different perspectives. Three studies conducted the analysis 
from a societal perspective and included intervention costs, costs to participants, healthcare 
costs and production losses [36, 37, 45]. Two studies included intervention costs, costs to 
participants and healthcare costs [38, 41]. Three studies assessed intervention costs and 
costs to participants [40, 43, 46] and one study included intervention costs and healthcare 
costs [39]. Three studies only included intervention costs [42, 44, 47]. In general, intervention 
costs were assessed using study records. Costs to participants and production losses were 
 
 
mainly quantified based on questionnaires. Healthcare costs were assessed using either 
questionnaires or healthcare practice records. A separate and detailed reporting of resource 
consumption and unit cost was not done in most of the studies, except for the ones 
originating from New Zealand [36-38] and a recent study from UK [39]. Costing year was not 
specifically reported in four studies [41, 43, 46, 47]. Only two studies separately reported 
fixed and variable costs [45, 46].  
3.3 Risk of bias and quality assessment 
Risk of bias was assessed for each study with the Cochrane risk of bias tool [24] and results 
are summarized in Table 3. Six out of twelve studies provided enough information to judge 
that random sequence generation and allocation concealment were adequate. Adequate 
blinding of personnel and blinding of outcome assessment was reported in four studies. 
Incomplete outcome data were addressed in eight studies. Risk of reporting bias was judged 
to be low in eleven studies. The quality assessment using the CHEC list [23] showed that 
most studies did not investigate costs from an appropriate perspective (societal), many 
studies did not report the costing year and several studies did not conduct an appropriate 
sensitivity analysis (see electronic supplementary Table S1). 
Table 3 Risk of bias summary table 
Reference Additional 
references 
Random 
sequence 
generation 
(selection bias) 
Allocation 
concealment 
(selection 
bias) 
Blinding of 
personnel 
(performance 
bias) 
Blinding of 
outcome 
assessment 
(detection bias) 
Incomplete 
outcome data 
addressed 
(attrition bias) 
Selective 
reporting 
(reporting bias) 
Harris et al. 
[39] 
 + + - + + + 
Ewald et al. 
[47] 
[55, 56] + + + + ? + 
Golsteijn et al. 
[45] 
[57] ? ? ? ? + + 
Iliffe et al. [40] 
 
+ + - - + + 
Leung et al. 
[38] 
[58] - - + + + + 
Elley et al. [36] [59] + + + + + + 
Van Keulen et 
al. [46] 
[60] + ? ? ? + + 
Finkelstein et 
al. [42] 
 
+ + - ? + + 
Sevick et al. 
[44] 
[61] ? ? ? ? ? ? 
Isaacs et al. 
[41] 
 
+ + - - + + 
Elley et al. [37] [62] + ? ? ? ? + 
Sevick et al. 
[43] 
[63-65] ? ? + + - + 
Coding of judgment: “+” low risk of bias; “?” unclear risk of bias; “-“ high risk of bias 
 
 
3.4 Results of trial-based economic evaluations  
Effects of the interventions varied widely. The highest effect on physical activity was seen in 
an intervention using financial incentives (Table 4). The effect was a gain of 1.17 MET-hours 
per day. However, it should be considered that this study had a follow-up duration of 4 
weeks, which is much smaller than all the other studies, which had a follow-up of at least 1 
year. Another intervention that was based on printed individualized motivationally tailored 
feedback showed a gain of 1.01 MET-hours per day, which can be considered equivalent to 
20 minutes of moderate physical activity per day [44]. Five interventions gained between 0.5 
and 1 MET-hour per day. These interventions included behavior change counseling or 
teaching, a combination of advice, goal setting and follow-up counseling, individualized 
feedback by telephone and instructor-led walking [36, 41, 43, 44, 47]. One intervention that 
used computer-tailored physical activity advice communicated via website and email had a 
negative effect (-0.06 MET-hours per day) [45]. All the other interventions had an effect 
between 0.1 and 0.5 MET-hours per day. 
Costs of interventions varied widely. The most expensive interventions were based on 
individualized motivationally tailored feedback communicated via telephone (US$1260 per 
person) or print (US$638 per person) [44]. However, these costs included recruitment and 
facility costs that were not included in any of the other studies. Four other interventions had 
costs higher than US$300 per person: One intervention combining advice, goal setting and 
follow-up counseling, two interventions based on exercise classes, and one behavior change 
teaching intervention [38, 40, 41, 43]. Seven interventions had costs lower than US$100 per 
person: three interventions with computer tailored physical activity advice communicated via 
print, two similar interventions communicated via web, one individualized step-related goal 
setting intervention plus one intervention combining advice, goal setting and follow-up 
counseling [36, 39, 45, 46]. All the other interventions had costs between US$100 per person 
and US$250 per person. 
 
 
The ICER varied widely among the interventions (Fig. 2). Four interventions showed an ICER 
below our benchmark between US$0.44 and US$0.63 per MET-hour gained, which is based 
on the health care costs and productivity losses of physical inactivity in Switzerland. These 
four interventions were based on individualized advice delivered in four different ways [45]: 
print (postal mail) or web (website and email) and in a basic form (standard advice) or with 
additional environmental components (e.g., walking and cycling routes and physical activity 
possibilities and initiatives in participants’ own neighborhood and home exercises). One other 
intervention that was based on behavior change counseling by telephone had an ICER of 
US$0.64 per MET-hour gained [47]. One pedometer-based individualized step-related goal 
setting intervention had an ICER of US$0.67 per MET-hour gained [39]. Another intervention 
was based on face-to-face advice, goal setting, follow-up face-to-face meeting and follow-up 
telephone counseling [36]. This intervention had an ICER of US$0.85 per MET-hour gained. 
All other interventions had an ICER above US$1.00 per MET-hour gained. 
 
 
Table 4 Detailed MET-hours gained, intervention costs and ICER of included studies 
Reference 
Follow-
up 
(months) Study arms 
MET-hours 
gained per 
person per 
day 
MET-hours 
gained per 
person 
Intervention 
costs per 
person (US$ 
2018) 
Δ effect 
(MET-hours 
gained) 
Δ costs (US$ 
2018) 
ICER 
(US$ 2018 
per MET-hour 
gained) 
Comments 
Harris et al. 
[39] 
12 (C) doing nothing 0.05 19.6 0.0    
  (I1) pedometer, individualized step-related goal setting print 0.40 144.7 83.5 125.1 83.5 0.67 
  (I2) pedometer, individualized step-related goal setting face-to-face plus 
counseling 
0.35 129.1 238.4 109.5 238.4 2.18 
Ewald et al. 
[47] 
12 (C) standardized brochure encouraging physical activity 0.14 49.8 0.0    Costs of control group 
(brochure) not plausible 
  (I1) behavior change counseling face-to-face 0.34 123.6 194.2 73.8 194.2 2.63* 
  
(I2) behavior change counseling telephone 0.84 307.1 163.6 257.4 163.6 0.64* 
Golsteijn et al. 
[45] 
12 (C) doing nothing -0.31 -114.7 0.0    
 (I1) individualized advice print basic 0.43 156.4 34.4 271.1 34.4 0.13 
 
  
(I2) individualized advice print environmental 0.39 140.8 41.7 255.5 41.7 0.16 
 
  
(I3) individualized advice web basic 0.10 36.5 20.7 151.2 20.7 0.14 
 
  
(I4) individualized advice web environmental -0.06 -20.9 25.1 93.9 25.1 0.27 
 
Iliffe et al. [40] 12 (C) doing nothing 0.02 7.6 0.0    
  (I1) class-based exercise 0.36 132.0 381.6 124.4 381.6 3.07 
 
  
(I2) home-based exercise 0.08 28.7 146.1 21.1 146.1 6.92 
 
Leung et al. 
[38] 
12 (C) face-to-face advice, goal setting and follow-up telephone counseling 0.17 61.1 318.4    
  (I) face-to-face advice, step-related goal setting, followed by telephone 
counseling 
0.30 109.9 397.4 48.9 79.0 1.62* 
 
Elley et al. [36] 12 (C) doing nothing 0.38 137.6 0.0    
  (I) face-to-face advice, goal setting and follow-up face-to-face meeting and 
telephone counseling 
0.61 224.2 73.3 86.6 73.3 0.85 
 
Van Keulen et 
al. [46] 
17 (C) doing nothing 0.25 125.9 0.0    
 (I1) individualized advice print 0.29 147.8 81.4 21.9 81.4 3.71 
  (I2) individualized advice telephone 0.26 131.4 152.7 5.5 152.7 27.89 
  
(I3) individualized advice print and telephone 0.31 158.8 114.2 32.9 114.2 3.48 
Finkelstein et 
al. [42] 
1 (C) fixed financial incentive 0.65 18.2 90.8    
 (I) variable financial incentives 1.17 32.7 145.3 14.5 54.5 3.77* 
 
Sevick et al. 
[44] 
12 (C) doing nothing 0.45 163.3 191.4    Costs include general 
office activities, 
recruitment cost and 
facilities costs 
  (I1) individualized feedback on physical activity telephone 0.58 211.8 1260.3 48.5 1068.8 22.03   
(I2) individualized feedback on physical activity print 1.01 369.7 638.1 206.4 446.7 2.16 
Isaacs et al. 
[41]  
12 (C) individualized advice only 0.17 61.2 0.0    Costs of control group 
(advice only) not 
plausible   (I1) exercise classes, advice and financial incentive 0.18 64.9 375.7 3.7 375.7 101.48* 
  
(I2) instructor-led walking program, advice and financial incentive 0.50 181.1 186.2 119.9 186.2 1.55* 
Elley et al. [37] 12 (C) doing nothing 0.12 43.8 0.0    
  (I) face-to-face advice, goal setting and follow-up telephone counseling 0.39 142.4 164.1 98.6 164.1 1.66 
 
 
 
Sevick et al. 
[43] 
24 (C) exercise prescription 0.69 503.7 1002.3    
  (I) behavior change teaching face-to-face 0.84 613.2 348.6 109.5 -653.7 -5.97* 
 
Legend: * ICER based on a comparator other than “doing nothing”; C = comparator; I = intervention; Δ = intervention – control group; ICER = incremental cost-effectiveness ratio; MET-hours gained per 
person = MET-hours gained per person per day multiplied with the number of days of follow-up to make the effect comparable to the costs and, therefore, allow to compare interventions with different 
follow-up times.
 
 
4 Discussion 
To the best of our knowledge, this study is the first to systematically review RCT-based 
economic evaluations of physical activity interventions for primary prevention or health 
promotion in adults. Four interventions that delivered individualized advice via print or web 
showed best value (physical activity gains) for money (intervention costs) with ICERs below 
the benchmark between US$0.44 and US$0.63 per MET-hour gained [45]. However, cost-
effectiveness results varied widely among interventions and only a small number of 
interventions would be cost-effective according to the benchmark applied. Furthermore, this 
study shows that trial-based evidence on cost-effectiveness of physical activity interventions 
is relatively scarce, confirming a finding from the first Economics of Physical Inactivity 
Consensus (EPIC) conference [15].  
Our focus on the rigorous RCT study design may be one reason why we found only a small 
number of cost-effective interventions [17]. Wu et al. [17] also showed higher effects in 
studies using subjective physical activity measures compared to objective measures. 
Therefore, it seems noteworthy that one study using accelerometry showed an ICER just 
above the benchmark although rather conservative results would be expected with such an 
objective measure [39]. Another study using pedometers also showed an ICER very close to 
the benchmark [47]. This intervention that was based on behavior change counseling by 
telephone, had a reasonable incremental effect of 0.71 MET-hours gained per person per 
day and showed an ICER of US$0.64 per MET-hour gained [47]. However, the ICER for this 
intervention was based on a comparator intervention other than “doing nothing”. It seems 
likely that the ICER would lie below the benchmark if compared to “doing nothing”. One other 
intervention was dominant, i.e. better and cheaper than the comparator [43]. However, the 
comparator was an active one (specifically, exercise prescription) and, therefore, the ICER 
cannot be directly compared to ICERs from studies with a “doing nothing” comparator.  
Intervention effects and costs from the studies included in our analysis are comparable to 
previous findings from studies that investigated evidence from trials (controlled trial, pre–post 
 
 
trial, or postmeasure-comparison approach) or model-based economic evaluations [17, 25, 
66]. The highest effect on physical activity (gain of 1.17 MET-hours per day compared to 
baseline) was observed in an intervention using variable financial incentives [42]. However, 
this study had a very short follow-up of 4 weeks and the intervention effect may not lead to 
substantial health benefits in a longer-term perspective. The second highest effect (gain of 
1.01 MET-hours per day) was shown for a print-based individualized motivationally tailored 
feedback intervention [44]. These interventions with the highest effect required more 
resources and therefore showed high costs. Although such more intensive interventions may 
not be cost-effective at the population level, they may be cost-effective in more targeted 
populations [17]. In Switzerland for example, we see a higher prevalence of physical 
inactivity in the French- and Italian-speaking language regions compared to the German-
speaking region [33]. In addition, populations with lower socioeconomic status show higher 
prevalence of physical inactivity. Targeting populations with similar cultural and 
socioeconomic characteristics may increase cost-effectiveness of physical activity 
interventions. 
The intervention by Goldsteijn et al. [45] that provided individualized advice delivered via web 
and included additional environmental components is a good example for showing a 
problematic aspect of cost-effectiveness analyses in the field. The intervention itself had a 
negative effect of -0.06 MET-hours gained per person per day when comparing physical 
activity at the one year follow-up versus baseline. However, compared to the “doing nothing” 
control group the incremental effect was 0.26 MET-hours gained per person per day, which 
is equivalent to approximately five minutes of moderate physical activity per person per day. 
Although this is a positive effect, it can be considered a relatively low incremental physical 
activity gain that is not sufficient to lead to substantial health benefits [67]. The annual 
intervention costs were US$25.14 per person. This leads to an ICER of US$0.27 per MET-
hour gained, which is below the benchmark. Therefore, the intervention is considered cost-
effective although the physical activity gain can be considered as not sufficient to lead to 
substantial health benefits. This issue was already raised by Wu et al. [17], who showed that 
 
 
some interventions that increased physical activity levels only by small amounts, such as 
stair climbing prompts, may be very cost-effective due to the very low intervention costs. 
Consequently, relying on cost-effectiveness alone might favor interventions that are unable 
to add substantial health benefits. The specifics of each intervention should therefore be 
considered and additional criteria such as minimal clinically relevant effectiveness thresholds 
might be used in future health policy decision-making. 
Cost-effectiveness may vary among settings and a previous study showed the limited 
comparability, generalizability and transferability of results from economic evaluations of 
physical activity interventions due to a high variability in costing methods [68]. Trial-based 
and model-based economic evaluations are complementary methods to assess cost-
effectiveness [13]. Our research shows the limited evidence available from trial-based 
economic evaluations. Consequently, transferability of trial-based economic evaluations and 
the use of data from trial-based economic evaluations as input for model-based economic 
evaluations gain in importance. As explained above, in model-based economic evaluations, 
data on the effect and the costs from different sources are combined in a decision-analytic 
model. 
We therefore agree with the EPIC statement that asks for high-quality RCTs with appropriate 
power and follow-up [15]. The statement also discusses other methodological challenges for 
economic evaluations of physical activity interventions such as the objective measurement of 
the intervention effect. Focusing more on the health economic aspects, we would stress the 
need to use available guidelines when conducting and reporting economic evaluations of 
physical activity interventions [23, 69]. Furthermore, we see an urgent need in reporting 
resource consumption and unit costs separately. This would not only increase transparency 
but also transferability of the results to other settings. In addition, the separate reporting of 
fixed and variable costs would facilitate the consideration of the cost-effectiveness when 
scaling-up physical activity interventions [70]. When reporting costs and effects, future 
studies should not only report means but also descriptors of statistical uncertainty. Another 
 
 
requirement for future studies is the use of “doing nothing” control groups, as this would 
increase the comparability of ICERs among studies.  
Several limitations need to be considered. The studies included in our analysis investigated 
different populations, comparators, settings, and follow-up durations and used different 
outcome measures. Therefore, interventions were too diverse to warrant mathematical 
comparison and it was decided to not provide summary estimates using meta-analysis 
techniques. In order to improve comparability, effect measures were standardized to MET-
hours gained per person per day. Although this method was used in previous studies, it may 
have some limitations when applied to broad outcomes such as step gains or proportions of 
populations meeting physical activity guidelines [17, 25]. In addition, many studies did not 
report sufficient statistical detail and, therefore, we were not able to properly address 
uncertainty. In order to assess the level of cost-effectiveness, we introduced a benchmark 
similar to that used in previous studies [17, 25]. Our benchmark was based on the health 
care costs and productivity losses of physical inactivity in Switzerland. Settings with different 
levels of prevalence of physical inactivity, health care spending or wages might choose 
different benchmarks for assessing cost-effectiveness of interventions to increase physical 
activity. The ICERs estimated in our study are based on the intervention costs and do not 
include potentially saved health care costs. Furthermore, we focused on interventions that 
can be implemented on a population-level and therefore excluded studies investigating the 
workplace setting. Some interventions focusing on the workplace setting have been 
previously shown to be cost-effective [71]. By limiting the study design to RCTs, we also 
excluded interventions targeting the built environment [17, 25, 72, 73]. As we excluded 
studies that did not report specific physical activity outcomes, we did not include studies only 
reporting quality-adjusted life-years as part of pure cost-utility analyses [74-76]. These 
studies showed varying results in terms of cost per quality-adjusted life-years gained by 
physical activity interventions. 
 
 
5 Conclusion 
We found evidence from RCTs indicating cost-effectiveness of some physical activity 
interventions. However, the majority of interventions assessed would not be cost-effective 
according to the benchmark applied. Some interventions increased physical activity levels 
only by small amounts, but were still cost-effective due to the very low intervention costs. 
Some interventions with relatively large intervention effects required more resources and, 
therefore, showed higher costs. Although such more intensive interventions may not be cost-
effective at the population level, they may be cost-effective in more targeted populations (e.g. 
for Switzerland: populations with similar cultural background or with similar socioeconomic 
status).  
Due to the relatively scarce trial-based evidence on the cost-effectiveness of physical activity 
interventions, we recommend that future studies investigating the efficacy or effectiveness of 
interventions aimed at reducing physical inactivity consider costs as an additional outcome of 
the study in order to assess cost-effectiveness. Such studies may not only investigate 
physical activity but overall lifestyle and consider well-being as an additional, separate 
outcome.  
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Figure Captions and Legends 
Fig. 1 PRISMA flow diagram of the systematic review 
 
Fig. 2 Incremental intervention costs and MET-hours gained (ICERs) in trial-based economic 
evaluations of physical activity interventions 
 
Legend: Δ refers to intervention minus comparator. The results from the study by Sevick et al. [43] were removed from the 
figure, as the cost difference was negative (US$ -654); this was based on a comparator intervention other than “doing nothing” 
(specifically, exercise prescription). 
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Abstract 
Background Physical inactivity causes a substantial health and economic burden globally. 
This study evaluated the cost-effectiveness of physical activity interventions for primary 
prevention with a health economic model presented for Switzerland as a conceivable 
example for other countries. 
Methods We built a proportional multistate life table model with a lifetime perspective for the 
adult population. Interventions evaluated included: individualized advice, pedometer, general 
practitioner (GP) referral and exercise prescription. Intervention effects were derived from 
randomized controlled trials and intervention costs based on a bottom-up approach. The 
effect of interventions on a comprehensive set of diseases was modelled with data from 
recent meta-analyses. Cost-effectiveness was evaluated in terms of cost per disability-
adjusted life-year averted compared to “doing nothing” as well as incremental cost-
effectiveness between interventions at national and language region level. 
Findings All four interventions were cost-saving and more effective compared to “doing 
nothing”, from a societal perspective. At national level and in the German-speaking region, 
individualized advice was the preferable intervention followed by GP referral. These two 
interventions dominated pedometer and exercise prescription. In the French- and Italian 
speaking regions, GP referral was the preferable and dominating intervention. However, 
results were subject to substantial uncertainty in the underlying key model input parameters. 
Interpretation We recommend that individualized advice and GP referral be further 
evaluated as interventions and that decision-making considers the specifics of the Swiss 
language regions. Furthermore, we judge the SPACE model to not only be relevant for 
Switzerland but also for other multicultural countries. 
Funding Health Promotion Switzerland. 
 
 
 
 
Research in context 
Evidence before this study: Physical inactivity causes substantial health and economic 
burden. This burden calls for interventions promoting physical activity. Such interventions 
should provide best value for money. Therefore, cost-effectiveness of physical activity 
interventions has been investigated in several health economic models designed for specific 
countries. 
Added value of this study: Our model assessed the cost-effectiveness of physical activity 
interventions at the Swiss national level and in the three language, thus cultural, regions from 
a societal perspective. A comprehensive set of diseases was included in the model. 
Implications of all the available evidence: 
Swiss policy makers have cost-effective options of physical activity promotion and should 
consider the specifics of language regions in order to allocate resources efficiently. Our 
model has the potential to be applied beyond Switzerland, primarily to high-income countries, 
as a tool to guide societal efforts in primary prevention of physical inactivity-related diseases. 
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Introduction 
Physical inactivity causes a substantial health and economic burden globally.1,2 Detrimental 
health consequences related to physical inactivity have been confirmed for cardiovascular 
diseases, diabetes, different types of cancer as well as musculoskeletal and mental health 
problems.3,4 The World Health Organization (WHO) recommends weekly physical activity of 
at least 150 minutes with moderate intensity or 75 minutes with vigorous intensity to achieve 
a health enhancing effect.  
In Switzerland, about one quarter of the population does not fulfill the WHO 
recommendations. However, the proportion of physically inactive people substantially differs 
between the three Swiss language regions: in the German-speaking region 21·0% of the 
adult population are physically inactive, whereas 32·6% are physically inactive in the French-
speaking region and 31·5% in the Italian-speaking region.5 In fact, language region has been 
shown to be a strong correlate of physical activity independent of socio‐demographic or 
environmental factors.6 Furthermore, the relationship between language and culture has 
been extensively studied and current concepts suggest an interactional relationship between 
the two.7 Therefore, Switzerland may serve as interesting example for other multicultural 
high-income countries. 
The burden of physical inactivity in Switzerland has been shown to be substantial and the 
French‐ and Italian‐speaking regions were over-proportionally affected.8 This considerable 
Swiss behavioral burden calls for interventions promoting physical activity. Policy makers 
should consider interventions that provide best value for money.9 Physical activity 
interventions, therefore, should not only be effective in improving health outcomes but also 
cost-effective. 
Several systematic reviews have investigated the cost-effectiveness of physical activity 
interventions.10 However, transferability of cost-effectiveness results between geographies 
and cultures can be challenging and subject to limitations.11 Health economic modelling can 
support decision-making, particularly in the absence of setting-specific data.12 Health 
 
 
economic models have been built for different countries to evaluate the cost-effectiveness of 
physical activity interventions.13-17 In the absence of a Swiss-specific model, this study 
developed a health economic model to assess the cost-effectiveness of physical activity 
interventions in Switzerland and its three language regions from a health care payer and 
societal perspective, with a potential for application to other multicultural settings. 
 
 
Methods 
Model overview 
We built the Swiss Physical Activity Cost-Effectiveness (SPACE) model as a proportional 
multistate life table model to evaluate the cost-effectiveness of physical activity interventions 
in Switzerland. SPACE adapted and further developed the ACE-Prevention approach from 
Australia.15 In the SPACE model, the population was tracked in a general life table and 
multiple diseases were modelled in parallel in separate life tables (Figure 1, disease 
model).15,18  The intervention model, as the second component of the SPACE model, 
estimated the impact of physical activity interventions on the modelled population in terms of 
metabolic equivalent (MET)-minutes gained. One MET is defined as the resting energy 
expenditure, which is equivalent to an oxygen consumption of 3·5 ml/kg/min. An increase in 
MET-minutes was fed back to the disease model, where it led to a decrease in disease 
incidence. Outcomes of the SPACE model were total physical activity intervention costs, 
costs offset due to averted health care spending and averted productivity losses, and health 
gains in terms of disability-adjusted life-years (DALYs). On this basis, incremental cost-
effectiveness ratios (ICERs) between interventions and “doing nothing” were calculated as 
costs per DALY averted.19 
At the national and language region level, we modelled the adult female and male population 
aged between 40 and 75 years in 2018. One-year age-sex cohorts were followed until death 
or a maximum age of 100 years. We purposeful chose a healthy population as a first step to 
provide a model in primary prevention. 
Model input parameters and data sources are explained in the appendix pp. 3-13. 
 
 
 
Figure 1 Schematic of the SPACE model 
 
Source: Adapted from the ACE-Obesity Policy model.20 
 
Disease model 
Eight diseases were included in the analysis: breast cancer (in females only), colorectal 
cancer, type 2 diabetes mellitus, coronary heart disease, ischemic stroke, osteoporosis, low 
back pain and depression. The first five diseases can be considered a “core set” as they are 
frequently used in health economic studies investigating physical activity.15,16 Osteoporosis, 
low back pain and depression have been taken into account less frequently.8,21 However, 
recent studies have shown that physical activity reduces the incidence of all these 
diseases.3,4,21 In the disease life tables, four different health states were modelled for each 
disease using the DisMod framework: healthy, diseased, dead from disease and dead from 
other cause.15 
 
Intervention model 
The intervention model considered the prevalence of different categories of physical activity 
and changes in energy expenditure within each category, expressed as MET-minutes per 
 
 
week, due to physical activity interventions. Four physical activity categories were modelled: 
inactive, partially active, sufficiently active, and exercising. 
The intervention model influenced the disease model via the PIF. We applied the “RR shift” 
method of the PIF,22 implying that physical activity interventions lower the relative risks (RRs) 
of disease within each physical activity category due to increased energy expenditure, but do 
not change the prevalence of each physical activity category. The lower category-level RRs 
due to interventions led to lower PIFs. PIFs were multiplied by the incidence rates in the 
disease model and lower PIFs, therefore, led to lower disease incidence. Consequently, 
physical activity interventions reduced the number of people with diseases. 
We evaluated four interventions in SPACE that were the most cost-effective interventions 
based on a recent systematic review of randomized controlled trial-based economic 
evaluations of physical activity interventions for primary prevention in adults.23 They reflect a 
range of concepts to promote physical activity and we judged their implementation to be 
feasible in Switzerland (Table 1): 
• Pedometer with individualized goal setting. Pedometers are given to participants, 
who receive individual targets for step counts over a period of 12 weeks plus a diary for 
daily step counts, all by mail.24 
• General practitioner (GP) referral to telephone-based counselling. GPs refer 
participants to an exercise physiologist for physical activity counselling. The counselling 
consists of one face-to-face session followed by four sessions delivered by phone over a 
period of 13 weeks.25 
• Individualized physical activity advice. Participants receive computer-tailored 
physical activity advice that is based on “personal characteristics, motivational readiness 
for behavior change, and needs”26 as assessed in a questionnaire. Text and illustrations 
are delivered to participants by mail at three time-points (2 weeks, 2 months and 4 
months).  
 
 
• Exercise prescription. Ten minutes of brief physical activity advice plus goal-setting 
(increasing physical activity to ≥30 minutes moderate-intensity physical activity five times 
per week) and a written exercise prescription given to participants by a primary 
healthcare nurse at the beginning of the intervention. The exercise prescription involves 
the provision of telephone-based physical activity counselling by an exercise facilitator 
over a period of 9 months (5 calls of 15 minutes each). In addition, a 30-minute face-to-
face consultation with a nurse was scheduled at 6 months.27 
Regarding intervention reach, we assumed that GP referral and exercise prescription would 
reach 10% of the population in the inactive and partially active categories. For pedometer 
and individualized advice, we assumed that 3% of the population in all physical activity 
categories would be reached. We applied intervention effects on physical activity from the 
second year onwards for three years (appendix p. 5). Applying intervention effects from the 
second year onwards accounted for the fact that intervention effects were based on 12-
month follow-up data. In the first year with effect (second year in the model), we assumed a 
full intervention effect. Thereafter, we applied a relative annual decay rate of 50% of 
intervention effect on physical activity.15,16  
Table 1 Overview of interventions evaluated in SPACE 
Interventions Intervention detail 
Intervention 
effect in MET-min 
gained per week 
Intervention cost in CHF 2018 
Set-up (fixed) cost Delivery of 
intervention 
(variable cost 
per person) 
Pedometer Pedometer and individualized step-related goal setting delivered by post 168·0 2,200,000 42·10 
General 
practitioner (GP) 
referral 
GP referral to behavior change 
counseling delivered by telephone 352·8 1,010,000 295·40 
Individualized 
advice 
Individualized physical activity advice 
delivered by post 180·6 3,100,000 8·60 
Exercise 
prescription 
Exercise prescription with telephone-
based counselling 256·2 1,010,000 253·45 
Abbreviations: CHF, Swiss francs; GP, general practitioner; MET, metabolic equivalent. 
See appendix pp. 7-10 for intervention cost details 
 
 
 
Model outcomes 
Life years gained were directly extracted from the life tables in the disease model and DALYs 
were estimated using disability weights from prevalent years lived with disability (YLD). 
Health care costs related to the medical treatment of diseases were estimated based on the 
number of prevalent cases and annual costs per disease. Productivity losses due to 
morbidity (i.e. presenteeism, absenteeism and early retirement), premature mortality and 
informal care were estimated in the model using the human capital approach. 
From a societal perspective, net costs were intervention costs minus averted health care 
costs (all direct medical costs irrespective of the payer) and averted productivity losses. From 
a health care payer perspective, net costs were intervention costs minus averted health care 
costs only. ICERs were estimated by dividing net costs by DALYs averted compared to 
“doing nothing”. In addition, an incremental analysis was conducted by comparing more cost-
effective interventions with their next best alternatives. A willingness-to-pay threshold of CHF 
100,000 per DALY was tentatively assumed to assess the cost-effectiveness of interventions. 
Interventions that led to more DALYs averted and were at the same time less costly 
compared to the alternative were categorized as “dominant”.28 
 
Sensitivity analysis 
We conducted multiple scenario analyses and a probabilistic sensitivity analysis ass detailed 
in the appendix p. 14. The SPACE model was developed in MS Excel (Microsoft, Redmond, 
WA) and used the Ersatz add-in to MS Excel to calculate outcomes for age-sex cohorts and 
to conduct PSA.29  
 
 
 
Role of the funding source 
Health Promotion Switzerland did partially fund this study. They were not involved in any of 
the following activities: in study design; in the collection, analysis, and interpretation of data; 
in the writing of the report; and in the decision to submit the paper for publication. 
 
 
 
 
Results 
Cost-effectiveness on the national level 
Life years lived longer and health gains differed substantially between the four interventions 
(Table 2). GP referral had the highest gains of 134 life years and 306 DALYs over the 
cohorts’ lifetime. The lowest gains were achieved with the pedometer intervention (41 life 
years and 133 DALYs). These differences in health gains were also reflected in differences 
in the reduction of health care costs and productivity losses. GP referral was responsible for 
the highest offsets of CHF -22·3 million (health care costs) and CHF -20·4 million 
(productivity losses). The pedometer intervention had the lowest offsets of CHF -10·4 million 
and CHF -8·9 million, respectively. Intervention costs also varied substantially. Individualized 
advice had the lowest costs with CHF 4·1 million and GP referral the highest with CHF 29·4 
million. 
From the societal perspective, all four interventions were cost-saving compared to “doing 
nothing”, as intervention costs were offset by averted health care costs and productivity 
losses. Furthermore, they were dominant, as all four interventions also gained life years and 
averted DALYs. When comparing interventions incrementally, individualized advice was the 
most cost-effective intervention and the next best alternative was GP referral with an ICER of 
CHF 19,632 per DALY averted, which is below the frequently assumed tentative willingness-
to-pay threshold of CHF 100,000 per DALY averted (appendix pp. 15-16). Pedometer and 
exercise prescription were dominated by the other two interventions. 
From the health care payer perspective, the pedometer and individualized advice 
interventions remained dominant when compared to “doing nothing”. For GP referral net 
costs were CHF 7·1 million and for exercise prescription CHF 9·1 million. This led to ICERs 
of CHF 23,044 and CHF 41,079 per DALY averted, respectively, for GP referral and exercise 
prescription. In the incremental analysis, individualized advice was the most cost-effective 
intervention and the next best alternative was GP referral with an ICER of CHF 86,503 per 
 
 
DALY averted. Pedometer and exercise prescription were again dominated by the other two 
interventions. 
Table 2 Cost-effectiveness of physical activity interventions as estimated in the deterministic 
base case analysis 
       Societal perspective Health care payer perspective 
Intervention Population size 
Population 
reached 
DALYs 
averted 
Health care 
cost offsets 
(million CHF) 
Productivity 
losses 
offsets 
(million CHF) 
Intervention 
cost (million 
CHF) 
Net 
cost 
(million 
CHF) 
ICER* 
(CHF/DALY) 
Net 
cost 
(million 
CHF) 
ICER* 
(CHF/DALY) 
Pedometer  3,887,024 116,610 133 -10·4 -8·9 7·1 -12·2 dominant -3·3 dominant 
GP referral  3,887,024 96,039 306 -22·3 -20·4 29·4 -13·4 dominant 7·1 23,044 
Individualized 
advice  3,887,024 116,610 143 -11·1 -9·6 4·1 -16·6 dominant -7·0 dominant 
Exercise 
prescription  3,887,024 96,039 222 -16·2 -14·8 25·4 -5·7 dominant 9·1 41,079 
Abbreviations: GP, general practitioner; DALYs, disability-adjusted life-years; CHF, Swiss francs; 
ICER, incremental cost-effectiveness ratio 
*compared to “doing nothing” 
 
Cost-effectiveness in the three language regions 
The results in the German-speaking region were comparable to the ones at the national level 
(Table 3). All four interventions were dominant from a societal perspective when compared to 
“doing nothing”. From a health care payer perspective, the pedometer and individualized 
advice interventions also remained dominant and the ICERs for GP referral and exercise 
prescription were below the tentatively assumed willingness-to-pay threshold of CHF 
100,000 per DALY averted. In the incremental analysis, individualized advice was the most 
cost-effective intervention and the next best alternative was GP referral, with ICERs of CHF 
45,977 and CHF 112,644 per DALY averted, respectively, from a societal and health care 
payer perspective. Pedometer and exercise prescription were dominated by the other two 
interventions. 
In the French- and Italian-speaking regions, all four interventions were dominant from a 
societal perspective when compared to “doing nothing”. When comparing the interventions 
with each other, GP referral dominated all three other interventions as it averted most DALYs 
 
 
at lowest net costs. From a health care payer perspective, however, individualized advice 
was the preferable option followed by GP referral. 
Table 3 Cost-effectiveness of physical activity interventions in the three language regions of 
Switzerland 
       Societal perspective Health care payer perspective 
Intervention Population size 
Population 
reached 
DALYs 
averted 
Health care 
cost offsets 
(million CHF) 
Productivity 
losses 
offsets 
(million CHF) 
Intervention 
cost (million 
CHF) 
Net 
cost 
(million 
CHF) 
ICER* 
(CHF/DALY) 
Net 
cost 
(million 
CHF) 
ICER* 
(CHF/DALY) 
French-speaking region 
Pedometer  974,773 29,243 34 -2·9 -2·4 1·8 -3·5 dominant -1·1 dominant 
GP referral  974,773 32,118 101 -8·0 -6·9 9·7 -5·2 dominant 1·7 16,856 
Individualized 
advice  
974,773 29,243 37 -3·1 -2·5 1·0 -4·6 dominant -2·1 dominant 
Exercise 
prescription  
974,773 32,118 74 -5·8 -5·0 8·4 -2·4 dominant 2·6 34,756 
German-speaking region 
Pedometer  2,737,993 82,140 92 -7·0 -6·2 4·6 -8·7 dominant -2·4 dominant 
GP referral  2,737,993 58,321 186 -13·1 -12·5 17·7 -7·9 dominant 4·6 24,714 
Individualized 
advice  
2,737,993 82,140 99 -7·5 -6·7 2·3 -11·9 dominant -5·2 dominant 
Exercise 
prescription  
2,737,993 58,321 135 -9·5 -9·1 15·3 -3·3 dominant 5·8 42,479 
Italian-speaking region 
Pedometer  174,258 5,228 6 -0·5 -0·3 0·8 -0·1 dominant 0·3 42,391 
GP referral  174,258 5,532 18 -1·4 -1·0 1·9 -0·4 dominant 0·5 29,589 
Individualized 
advice  
174,258 5,228 7 -0·5 -0·4 0·8 -0·1 dominant 0·3 41,567 
Exercise 
prescription  
174,258 5,532 13 -1·0 -0·7 1·7 -0·0 dominant 0·7 51,558 
Abbreviations: GP, general practitioner; DALYs, disability-adjusted life-years; CHF, Swiss francs; 
ICER, incremental cost-effectiveness ratio 
*compared to “doing nothing” 
 
Sensitivity analysis 
Pedometer and individualized advice remained cost-saving in all scenario analyses from a 
societal perspective (appendix pp. 17-20). GP referral was no longer cost-saving when the 
duration of effect was set at one year instead of three years. Exercise prescription was no 
longer cost-saving when the duration of effect was set at one year instead of three years; when 
the intervention effect was assumed 30% lower than in the base case analysis; when 
intervention costs were assumed 30% higher; and when health care costs and productivity 
losses were assumed 30% lower. DALYs averted were most influenced by the percentage of 
population reached and the duration of effect. The inclusion of osteoporosis, low back pain and 
 
 
depression had a substantial impact on the results, in such that without these three diseases 
only individualized advice remained cost-saving from a societal perspective. 
In the probabilistic sensitivity analysis, the uncertainty underlying some of the key model 
input parameters led to substantial variation in the model outcome (Figure 2). This is also 
reflected in the cost-effectiveness acceptability curves (Figure 3). From a societal 
perspective, the probability for being cost-saving was highest for individualized advice (73%) 
and lowest for exercise prescription (45%) (Table 4). The probabilities for an ICER below 
CHF 100,000 per DALY averted were 82% for GP referral and 72% for exercise prescription. 
Table 4 Probabilistic sensitivity analysis results for physical activity interventions, compared 
to “doing nothing” 
  Societal perspective Health care payer perspective 
Intervention 
DALYs averted 
(base case)* 
Net cost in 
million CHF 
(base case)* Probability of being cost-
saving 
Probability of 
being better 
than 
CHF100,000
/DALY 
averted 
Net cost in 
million CHF 
(base case)* Probability of being cost-
saving 
Probability of 
being better 
than 
CHF100,000
/DALY 
averted 
Pedometer  149 (133) -11·0 (-12·2) 68% 78% -2·7 (-3·3) 61% 79% 
GP referral  316 (306) -2·8 (-13·4) 99% 100% 14·8 (7·1) 2% 100% 
Individualized advice  162 (143) -15·6 (-16·6) 74% 81% -6·5 (-7·0) 73% 84% 
Exercise prescription  229 (222) 2·9 (-5·7) 92% 100% 15·6 (9·1) 0% 100% 
Abbreviations: GP, general practitioner; DALYs, disability-adjusted life-years; CHF, Swiss francs;  
* Deterministic base case results for comparison. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Cost-effectiveness results of physical activity interventions from probabilistic 
sensitivity analysis 
 
Abbreviations: GP, general practitioner; DALYs, disability-adjusted life-years; CHF, Swiss francs;  
* Deterministic base case results for comparison. 
Grey dots represent 2,000 simulations run as part of the probabilistic sensitivity analysis. Black dots 
indicate mean values from the probabilistic sensitivity analysis. Results are shown for both 
perspectives, health care payer and societal.  
 
 
 
Figure 3 Cost-effectiveness acceptability curves for physical activity interventions 
 
Abbreviations: GP, general practitioner; DALYs, disability-adjusted life-years; CHF, Swiss francs;  
* Deterministic base case results for comparison. 
This figure shows cost-effectiveness acceptability curves for all four interventions from the health care 
payer (left panel) and societal (right panel) perspectives. The curves indicate the probabilities of being 
cost-effective (y-axis) at different willingness-to-pay thresholds (x-axis).  
 
 
 
Discussion 
SPACE is the first health economic model to evaluate the cost-effectiveness of physical 
activity interventions in Switzerland. From a societal perspective and irrespective of language 
and thus cultural region, all four interventions, namely individualized advice, pedometer, GP 
referral and exercise prescription, were cost-saving and more effective compared to “doing 
nothing”. At the national level and in the German-speaking region, individualized advice was 
the preferable intervention followed by GP referral. These two interventions dominated 
pedometer and exercise prescription. In the French- and Italian speaking regions, GP referral 
was the preferable intervention that dominated the three others. From a health care payer 
perspective, however, individualized advice was the preferable intervention followed by GP 
referral. The uncertainty underlying key model input parameters led to substantial variation in 
the modelled results, according to the probabilistic sensitivity analysis. 
In general, results for the health care payer perspective estimated in SPACE seemed to be 
comparable to the ones from previous physical activity models built for other countries. 
Compared to Cobiac et al.15, who investigated the cost-effectiveness of physical activity 
interventions for Australia, results for the pedometer intervention were similar, the ICER for 
exercise prescription worse and the one for GP referral better. Our more favorable results for 
GP referral were explained by the use of intervention effects from a more recent study.25 
Furthermore, our results for the pedometer intervention were comparable to the ones by 
Anokye et al.13 and more favorable than the ones estimated by Over et al.17 and Gc et al.16 
because we included more diseases related to physical inactivity. 
Although individualized advice was the most cost-effective strategy on the national level, it 
should be highlighted that health benefits in terms of DALYs averted were rather small (143 
DALYs). The burden of physical inactivity in Switzerland was estimated at 40,433 DALYs for 
the year 2013.8 Therefore, individualized advice would avoid less than 0·5% of the annual 
DALYs caused by physical inactivity. The issue of interventions that increase health benefits 
by small amounts only but may be cost-effective due to small intervention costs has already 
 
 
been raised in previous studies.23,30 Consequently, relying on cost-effectiveness alone might 
favor interventions that are unable to add substantial health benefits. GP referral added more 
health benefits than individualized advice at different net costs. While individualized advice 
was the preferable option in the regions with lower prevalence of physical inactivity, GP 
referral was preferable in the regions with higher prevalence. This finding shows that more 
intensive interventions have the potential for being cost-effective in populations at higher risk 
despite not being cost-effective at the population level.23  
We compared the four physical activity interventions under study with “doing nothing” and 
incrementally with each other. If the interventions were able to reach different sub-
populations, they could be considered truly independent and leading to additive effects. This 
would support the comparison with “doing nothing”. In light of potential cost savings, it would 
imply that several of the studied interventions could sensibly be implemented in parallel. 
However, as individualized advice and pedometer both recruit participants via public 
campaigns, independence of the interventions is questionable. The same holds for GP 
referral and exercise prescription as both recruit participants via GPs. Therefore, our 
additional, incremental comparison assumed mutual exclusivity of the four interventions in 
the sense that they interact and lead to non-additive effects when implemented in the same 
population.31 In reality, there be a situation of partial mutual exclusivity; one policy implication 
might be to consider co-implementation of individualized advice and GP referral in parallel. 
The available budget, and not just cost-effectiveness, may influence such choices. 
According to our knowledge, this study is the first in the field to include productivity losses in 
the cost-effectiveness assessment of physical activity interventions, adopting a societal 
perspective. Previous studies mainly focused on health care costs, while the PRIMEtime CE 
model by Briggs et al.14 also included social care costs for those aged above 75 years. The 
estimated averted productivity losses in the SPACE model were substantial, 10-15% lower 
than the averted health care costs. This is consistent with studies estimating the economic 
burden of physical inactivity.32 
 
 
Fixed and variable intervention costs were modelled separately in SPACE to account for the 
fact that the use of certain resources is independent of the number of people receiving the 
intervention.33 This separation of fixed and variable costs was another reason for different 
results between language regions besides the already mentioned influence of different 
prevalence of physical inactivity. In the Italian- and French-speaking regions, target 
populations were smaller and, thus, fewer people were reached by the interventions 
compared to the German-speaking region. Therefore, fixed intervention costs may 
substantially influence cost-effectiveness when the scale of the intervention substantially 
differs. 
Strengths of our model, in summary, are the inclusion of a societal perspective of cost 
assessment, the consideration of fixed and variable intervention costs and intervention 
effects stemming from randomized controlled trials. In addition, we included osteoporosis, 
low back pain and depression to gain a comprehensive understanding of diseases related to 
physical inactivity. As shown in the scenario analysis, this had a substantial impact on the 
results. Furthermore, epidemiological data used were consistent, as derived from the GBD 
study.34 Moreover, the language-region specific estimation of cost-effectiveness reflected 
previous findings which showed that the economic burden due to physical inactivity 
substantially differed between language regions.8 
The main limitation of our model is the uncertainty arising from the use of a range of 
heterogeneous secondary data sources and assumptions. Although RRs for disease 
incidence were taken from recently published meta-analyses that investigated dose-
response relationships, they were not based on a standardized definition and measurement 
of physical activity. Furthermore, we assumed equal RRs across gender and age‐groups. We 
may have underestimated the prevalence of physical inactivity as the Swiss Health Survey 
investigates self‐reported activity levels.35 Irrespective of these common issues, our effect 
estimates are consistent in that both prevalence and RRs were based on self‐reported 
physical activity levels. As a further limitation, productivity losses were likely underestimated 
 
 
because some domains such as presenteeism, early retirement and informal care could not 
be considered for some diseases due to limited data availability from literature. Although we 
tried to be comprehensive with diseases related to physical inactivity, there may be other 
diseases for which physical inactivity will be established as a risk factor, such as dementia 
and Alzheimer’s disease. Due to currently conflicting evidence, these diseases were not 
included in our model.36 Furthermore, multistate life table models assume independence in 
disease effects, while for example the occurrence of cardiovascular diseases is not 
independent from type 2 diabetes mellitus.14 Our analysis was not comprehensive in terms of 
interventions considered. Focusing on interventions that can be implemented at the 
population-level, we excluded interventions targeting specific populations such as worksite 
populations.37 In addition, we included only interventions that were investigated in 
randomized controlled trials. This implied the exclusion of interventions targeting the built 
environment.30,38 The SPACE model currently focuses on the adult population and does not 
allow for a holistic life course approach. Such an approach may be taken in future models, 
which would then allow us to also analyze the cost-effectiveness of interventions targeting 
children. 
In conclusion, we hope to inform efficient resource allocation and evidence-based decision-
making in primary prevention in Switzerland. We recommend that individualized advice and 
GP referral be further evaluated as interventions and that decision-making considers the 
specifics of the Swiss language regions. Furthermore, we judge the SPACE model to be not 
only relevant for Switzerland but also for other multicultural countries. Based on similar data 
availability, the SPACE model has the potential to be applied beyond Switzerland, primarily 
to high-income countries with a comparable background, as a tool to guide societal efforts in 
primary prevention of physical-inactivity-related diseases. 
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Supplementary Appendix 
 
 
 
 
 
 
 
1 Modelling approach 
Although each modelling method has its advantages and disadvantages, we deemed the proportional multistate 
life table modelling approach implemented in SPACE to be a good fit for physical activity modelling as it 
allowed for relatively easy consideration of multiple diseases, comorbidity and increased life expectancy.1-3 
Previous models investigating cost-effectiveness of physical activity interventions included decision trees4,5, 
Markov models6-10, microsimulation models11 as well as multistate life table models12-15. Multistate life table 
models were also used to assess other risk factors for non-communicable diseases such as smoking and 
unhealthy diet.16-26 
 
 
 
 
 
2 Model input parameters and data sources 
2.1 Disease model 
Age- and sex-specific population counts and total mortality rates were obtained from the Swiss Federal 
Statistical Office.27  
Disease life tables were mainly informed by data from the global burden of disease (GBD) 2017 study.17 In an 
alternative scenario, we used Swiss-specific epidemiological data for the diseases for which we could source 
information from the Swiss National Institute for Cancer Epidemiology and Registration 28, the Swiss Health 
Survey 29 and mortality statistics.27 (Table 1). We chose the GBD study as the primary source given the ready 
availability of detailed data and its wide use in the burden of disease and comparative risk assessment 
literature.12,17,30 In addition, using GBD data implied that all epidemiological input data were estimated using the 
same methodological framework.31 Epidemiological data were processed in the DisMod II software before 
serving as input data in SPACE in order to derive unknown epidemiological quantities and to create a set of 
consistent epidemiological parameter values.32 The same approach was followed in previous public health 
economic modelling studies.2,12-14,17,18 
 
Table 1 Overview of epidemiological input data 
Disease Incidence Prevalence Disease-specific mortality Case-fatality rate Remission 
Breast cancer 
(female) GBD 2017 
33 BC: GBD 2017 AS: NICER 28 GBD 2017 Dismod II Dismod II 
Colorectal cancer GBD 2017 BC: GBD 2017 AS: NICER GBD 2017 Dismod II Dismod II 
Type 2 diabetes 
mellitus GBD 2017 
BC: GBD 2017 
AS: SHS 2017 34 
BC: GBD 2017 
AS: DeathStat 2016 
27 
Dismod II Assumed no remission 
Coronary heart 
disease GBD 2017 GBD 2017 
BC: GBD 2017 
AS: DeathStat 2016 Dismod II 
Assumed no 
remission 
Ischemic stroke BC: GBD 2017 AS: SHS 2017 35 GBD 2017 
BC: GBD 2017 
AS: DeathStat 2016 
BC: no input 
AS: SHS 2017 35 
Assumed no 
remission 
Osteoporosis 
(GBD category 
“falls”*) 
GBD 2017 BC: GBD 2017 AS: SHS 2017 36 GBD 2017 Dismod II 
Assumed no 
remission 
Low back pain GBD 2017 BC: GBD 2017 AS: SHS 2017 37 
Assumed no 
disease-specific 
mortality 
Dismod II Dismod II 
Depression (GBD 
category “major 
depressive 
disorder”) 
GBD 2017 BC: GBD 2017 AS: SHS 2017 38 
Assumed no 
disease-specific 
mortality 
Dismod II BC: no input AS: 35.4% 39 
Abbreviations: AS, Alternative Scenario; BC, Base Case; DeathStat, Cause of Death and Stillbirth Statistics; 
GBD, Global Burden of Disease; NICER, National Institute for Cancer Epidemiology and Registration; SHS; 
Swiss Health Survey. 
*Causes of death and disability are often “categorized according to cause of injury (i.e., falls), not nature of 
injury (i.e., fracture)”.40 
Note: Citations are provided at the first mentioning of each distinct source. For osteoporosis, incidence, 
prevalence and disease-specific mortality were all adjusted for the proportion of falls resulting in fractures, using 
the estimates provided in the meta-analysis by Morrison et al.41. Alternative scenarios with higher parameter 
values than the corresponding (GBD) base case values are in bold type. Alternative scenarios with lower 
parameter values than the corresponding (GBD) base case values are underlined. Alternative scenarios where 
values were not consistently higher or lower than the corresponding (GBD) base case values are in italics. 
 
We also accounted for disease incidence trends based on GBD estimates for incidence rates across all ages, 
separately for women and men, for the last 15 years (Table 2).18 Based on these data, we estimated average 
annual percentage changes (AAPCs). AAPCs were applied in the first 15 years of the model as simple 
multiplicative factors affecting incidence. After 15 years, we assumed no further changes in disease incidence.  
 
 
 
 
Table 2 AAPCs for disease incidence between 2003 and 2017 
Disease sex AAPC (%) 95% CI LB (%) 95% CI UB (%) 
Breast cancer women -0.919 -2.033 0.194 
Colorectal cancer 
men -0.450 -2.321 1.421 
women -0.579 -2.651 1.493 
Coronary heart disease 
men 0.513 -0.303 1.329 
women -0.571 -1.517 0.374 
Ischemic stroke 
men 1.179 -0.089 2.447 
women 0.951 -0.451 2.354 
Type 2 diabetes mellitus 
men 0.971 0.369 1.573 
women 0.654 -0.028 1.337 
Osteoporosis (falls) 
men -2.125 -2.305 -1.945 
women -1.299 -1.456 -1.142 
Low back pain 
men 0.576 0.408 0.744 
women 0.351 0.201 0.500 
Depression (major depressive 
disorder) 
men -0.645 -0.917 -0.372 
women -0.651 -0.873 -0.430 
Source: Own calculations based on data from GBD Results Tool.33 
Abbreviation: AAPC, Average Annual Percentage Change; CI, Confidence Interval; GBD, Global Burden of 
Disease; LB, Lower Bound; UB, Upper Bound. 
Explanation: For women, low back pain incidence increased, on average, by 0.351% per year between 2003–
2017. 
 
2.2 Intervention model 
2.2.1 Overview 
The population prevalence of each physical activity category was estimated based on the Swiss Health Survey.29 
Energy expenditure in MET-minutes per week was assigned to each physical activity category according to the 
Swiss Health Survey and the compendium of physical activities (see sections 2.2.2 and 2.2.3).42 The relationship 
between energy expenditure and RRs was modelled based on published meta-analyses.43-46 
Measures of intervention effects from the trials were standardized as MET-minutes gained per week.47 To 
estimate fixed and variable intervention costs, we used a bottom-up approach with current Swiss prices. 
Resource consumption was as reported in the trials where available; otherwise, we made assumptions (see 
section 2.2.4). For the language-region-specific analyses, we assumed a separate implementation and, therefore, 
that half of the fixed intervention costs would be incurred in the German-speaking region and a quarter each in 
the French- and Italian-speaking regions of Switzerland. 
Two specific modelling aspects requiring attention are time lag between increased physical activity and observed 
health benefits as well as the decay of intervention effects. While energy expenditure might change quickly in 
response to a physical activity intervention, health effects might occur with some delay.13,21 However, there is no 
robust evidence regarding the length of the time lag between increased physical activity and observed health 
benefits.2 Some evidence suggests that this time lag may be relatively short48,49, while older evidence indicates 
that time lags may be shorter for cardiovascular diseases and longer for cancers50,51. Most previous physical 
activity modelling studies did not consider time lags. Two studies mentioned, but did not model, them.13,52 One 
study included time lags in scenario analyses and showed that no time lags resulted in increased estimates of 
health benefit.2 We applied intervention effects from the second year onwards, accounting for the fact that 
estimates of intervention effects were based on 12-month follow-up data. Furthermore, we assumed a relative 
annual decay rate of 50% for all intervention effects, which is in line with previous models.11,13 Other models 
assumed full intervention effects over a time period of 5 to 10 years.8 
 
 
 
 
2.2.2 Prevalence of physical activity categories 
The 2017 prevalence of the different physical activity categories in Switzerland and each language region was 
sourced from the Swiss Health Survey [SHS].29 In the SHS, respondents reported if and how often they engaged 
per week in physical activity that made them sweat. Respondents also supplied estimates of how long, on 
average, they were active on their “active days” (for a discussion of the potential underestimation of physical 
inactivity prevalence due to self-reporting, see 53). 
Based on these answers, we estimated the proportions of the Swiss population who were:29 
• Inactive: Less than 30 minutes of moderate physical activity or engaging in intense physical activity less 
than once per week 
• Partially active: 30–149 minutes of moderate physical activity or engaging in intense physical activity 
once per week 
• Sufficiently active: At least 150 minutes of moderate physical activity or engaging in intense physical 
activity twice per week 
• Trained: Engaging in intense physical activity at least three times per week 
Prevalences were calculated for 5-year age groups and for both sexes separately (Figure 1). Data were available 
up to age 75 years. We assumed that the prevalence reported for age 75 years applied to all higher age groups. 
Regarding the prevalence of each physical activity category in 5-year age groups and by sex in the language 
regions, we observed small numbers of respondents for some age and sex-specific physical activity categories in 
some language regions (e.g. the Italian-speaking region). In order to get more robust estimates, we therefore 
assumed that age and gender distribution within each physical activity category did not differ between language 
regions. 
Figure 1 Prevalence of physical activity categories in Switzerland 2017 
 
Source: Swiss Health Survey 2017.29 
Explanation: Proportions of self-reported levels of physical activity for women and men. For both sexes, the 
proportion of “trained” people declined with age. The largest share of “inactive” people was in the highest age 
group for both sexes. 
 
 
 
 
 
2.2.3 Mapping MET-minutes to physical activity categories 
MET-minutes per week were assigned to each physical activity category (Section 3.2.1) according to data from 
the Swiss Health Survey 2017.29 The International Physical Activity Questionnaire [IPAQ] had previously been 
included in the Swiss Health Survey but was not part of the 2017 wave.54 Therefore, we had to estimate the 
MET-minutes per week with another method. 
We first evaluated the days per week with activities that lead to at least some sweating (low- to moderate-
intensity physical activity) (TKOBW09: “Anzahl Tage pro Woche mit Aktivitäten, wo Sie zumindest ein 
bisschen ausser Atem kommen, aber nicht unbedingt ins Schwitzen. Das sind zum Beispiel zügiges Laufen, 
Wandern, Tanzen, Gartenarbeiten oder verschiedene Sportarten”). 
In the next step, we analyzed the average duration per day with low- to moderate-intensity physical activity 
(TKOBW11: “Durchschnittliche Dauer in Minuten pro Tag der oben beschriebenen Aktivität”). Values lower 
than 10 minutes were set to 0 in accordance with the IPAQ scoring guidance as the scientific evidence indicates 
that episodes or bouts of at least 10 minutes were required to achieve health benefits. We then took the days of 
low- to moderate-intensity physical activity per week and multiplied it by the average duration per day of low- to 
moderate-intensity physical activity to get the median minutes of low- to moderate-intensity physical activity per 
week. The minutes of low- to moderate-intensity physical activity per week were then multiplied by 3 METs to 
get to the MET-minutes per week of low- to moderate-intensity physical activity.47 Four METs instead of 3 
METs were included in the scenario analysis. 
The minutes of high-intensity physical activity per week were analyzed based on the answers given in the Swiss 
Health Survey regarding “minutes per week of gymnastics, fitness and sports” (SKOBW12: “Minuten pro 
Woche Gymnastik, Fitness, Sport”). Values lower than 10 minutes were set to 0 with the same rationale as for 
the low- to moderate-intensity physical activity. The minutes of high-intensity physical activity per week were 
then multiplied by 6 METs to get the MET-minutes per week of high-intensity physical activity.55 Eight METs 
instead of six METs were included in the scenario analysis.  
Total MET-minutes per week of physical activity were estimated by adding the MET-minutes per week of high-
intensity physical activity to the MET-minutes per week of low- to moderate-intensity physical activity. This 
approach allowed us to calculate sex-specific (but not age-specific) MET-minutes for each physical activity 
category (Table 1). We further assumed that MET-minutes per physical activity category do not differ between 
language regions. 
Table 3 Mapping MET-minutes to physical activity categories 
Sex PA level Scenario MET-minutes per week 
Women 
Inactive 
Base case (3 METs for light, 6 METs for 
vigorous PA) 
0 
Partially active 360 
Sufficiently active 1,620 
Trained 2,514 
Inactive 
Alternative scenario (4 METs for light, 
8 METs for vigorous PA) 
0 
Partially active 480 
Sufficiently active 2,160 
Trained 3,352 
Men 
Inactive 
Base case (3 METs for light, 6 METs for 
vigorous PA) 
0 
Partially active 360 
Sufficiently active 1,620 
Trained 2,610 
Inactive 
Alternative scenario (4 METs for light, 
8 METs for vigorous PA) 
0 
Partially active 480 
Sufficiently active 2,160 
Trained 3,480 
Source: Mattli et al.47,53 using the Swiss Health Survey 29,53 and the Ainsworth Compendium 42,56. 
Abbreviation: MET, Metabolic Equivalent; PA, Physical Activity. 
 
2.2.4 Intervention costs 
Intervention set-up and delivery costs were estimated with a bottom-up approach using information from the 
original studies57-60 and current tariffs/prices for Switzerland (Table 2). Standard deviations [SDs] for each cost 
were assumed to be 10% of the mean. We applied the same intervention costs to both sexes and all ages, for the 
first modelled year. 
 
 
 
 
Table 4 Overview on intervention costs 
Intervention type Set-up costs (fixed costs, CHF, 2018) Delivery of intervention (variable costs, per participant, CHF, 2018) 
Pedometer 60 2,200,000 42.10 
GP referral 58 1,010,000 295.40 
Individualized advice 59 3,100,000 8.60 
Exercise prescription 57 1,010,000 253.45 
Source: Own calculation, see subsequent sections for details 
Abbreviation: CHF, 2018 Swiss francs 
 
Pedometer with individualized goal setting 
Set-up costs (fixed costs): CHF 2,200,00 
• Transferring intervention to Swiss setting: The intervention has already been designed. Relevant 
information has been published open access and can be unrestrictedly used, distributed and reproduced 
in any medium provided the original work is properly cited.60 Therefore, costs are mainly related to 
translation into German, French and Italian. We assume that these costs would be approximately CHF 
100,000. 
• Participants have to be aware of intervention: One option would be that GPs recruit participants. In 
order to do this, GPs would need to be aware of the intervention (this is related to costs). Afterwards, 
GPs need time to identify the right participants. We assume that this would take at least 10 minutes. 
According to TARMED (position 00.0010 + 00.0030), this would yield costs of CHF 24.85 (27.92 tax 
points; 0.89 tax point value for the canton of Zurich).61,62 Another option could be a big public 
campaign (similar to what has been done for smoking cessation). We assume that such a campaign 
would be related to costs of approximately CHF 2 million. As the costs for a public campaign are higher 
than if the GPs recruited the participants, we further consider only the costs for the public campaign 
• Staff coordinating and delivering intervention: CHF 100,000 
Delivery of intervention (variable costs; per participant): CHF 42.10 
• Pedometer: CHF 40.00 
• Handbook including step count diary: CHF 1.00 
• Envelope for posting pedometer and handbook: CHF 0.10 
• Stamps for posting: CHF 1.00 
 
GP referral to telephone-based counselling  
Set-up costs (fixed costs): CHF 1,010,000 
• Transferring intervention to Swiss setting: Designing a referral letter template that afterwards can be 
easily personalized by the GP. We assume that these costs would be approximately CHF 10,000. 
• GPs have to be aware of intervention: We assume that creating awareness including some “training” 
would be related to costs of approximately CHF 1 million. 
Delivery of intervention (variable costs; per participant): CHF 295.40 
• Referral costs: We assume 15 minutes consultation time (including writing the referral letter). 
TARMED positions 00.0010 + 00.0020 + 00.0030: CHF 41.40 (46.53 tax points; 0.89 tax point value 
for the canton of Zurich).61,62 
 
 
 
 
• Costs for exercise physiologist: 4.4 consultations or 134 minutes total consultation time (this is 
approximately 30 minutes per consultation). Physio tariff 7301 (48 tax points per consultation). Plus for 
one time position 7350 (24 tax points). Total: CHF 254.00 ((4.4 x 48 tax points + 1 x 24 tax points) x 
1.08 tax point value for the canton of Zurich).63 
N.B.: No such profession as “exercise physiologist” currently exists in Switzerland. We do not take into 
consideration the costs related to “building such a profession”. We assume that such a profession does exist, 
those professionals know what to do and are reimbursed similar to a physiotherapist or a nutritionist. 
 
Individualized physical activity advice 
Set-up costs (fixed costs): CHF 3,100,000 
• Transferring intervention to Swiss setting: A computer-tailored intervention requires:64 (1) a 
questionnaire collecting characteristics of the participant; (2) a data warehouse containing the 
intervention messages that may be needed; (3) decision rules selecting messages matched to the 
characteristics of the participant; (4) a letter delivering the messages to the participant. All these aspects 
have already been designed. However, it is unknown if the information, including the software, could 
be purchased. The purchasing (and tailoring, including translation, in order to adapt it to the Swiss 
setting), or otherwise the Swiss-specific re-development, would be related to costs. Cost assumption: 
CHF 1 million 
• Participants have to be aware of intervention: One option could be a big public campaign (similar to 
what has been done for smoking cessation). We assume that such a campaign would be related to costs 
of approximately CHF 2 million 
• Staff coordinating and delivering intervention: CHF 100,000 
Delivery of intervention (variable costs; per participant): CHF 8.60 
• Questionnaires for participants (print-out; includes first and second questionnaire): CHF 0.50 
• Envelope for posting questionnaires: CHF 0.10 
• Stamps for posting: CHF 1.00 
• Pre-stamped return envelope (envelope plus stamp): CHF 1.10 x 2 (first and second questionnaire) 
• Advice letter for participant (print-out): CHF 0.50 x 3 (tailored physical activity advice at three time 
points) 
• Envelope for posting advice letter: CHF 0.10 x 3 (tailored physical activity advice at three time points) 
• Stamps for posting: CHF 1.00 x 3 (tailored physical activity advice at three time points) 
 
Exercise prescription with telephone-based counselling 
Set-up costs (fixed costs): CHF 1,010,000 
• Transferring intervention to Swiss setting: Translating exercise/lifestyle script that afterwards can be 
easily personalized by the primary care nurse. We assume that these costs would be approximately CHF 
10,000 
• GPs/primary care nurses have to be aware of intervention: We assume that creating awareness including 
some “training” would be related to costs of approximately CHF 1 million 
 
 
 
 
Delivery of intervention (variable costs; per participant): CHF 253.45 
• Initial brief advice: 10 minutes, includes time for personalizing written exercise/lifestyle script. 
TARMED positions 00.0010 + 00.0030: CHF 24.85 (27.92 tax points; 0.89 tax point value for the 
canton of Zurich).61,62 
• Written exercise script (print-out): CHF 0.50 
• 6-month follow-up visit with primary care nurse: 30 minutes. TARMED positions 00.1430 + 00.1440: 
CHF 72.60 (81.56 tax points; 0.89 tax point value for the canton of Zurich).61,62 
• Telephone support from exercise specialist: five calls per participant lasting 15 min each. Physio tariff 
7301 divided by two because one call only lasts 15 minutes instead of 30 minutes (24 tax points per 
call; this value is also very close to the 22 tax points for position 7340). Plus one time position 7350 (24 
tax points). Total: CHF 155.50 ((5 x 24 tax points + 1 x 24 tax points) x 1.08 tax point value for the 
canton of Zurich).63 
N.B.: No such profession as “exercise specialist” currently exists in Switzerland. We do not take into 
consideration the costs related to “building such a profession”. We assume that such a profession does exist, 
those professionals know what to do and are reimbursed similar to a physiotherapist or a nutritionist 
 
2.3 Model outcomes 
To estimate DALYs, the total number of YLD were divided by the total number of prevalent cases in order to get 
an average (across all sequela) disability weight for the Swiss population with a specific disease (Table 5). 
Estimates for both parameters were available from GBD, for the same time period.33 
Table 5 Disability weights 
Disease Mean disability weight Standard deviation of disability weight 
Breast cancer 0.0763 0.015 
Colorectal cancer 0.0906 0.016 
Type 2 diabetes mellitus 0.0681 0.015 
Coronary heart disease 0.0391 0.008 
Ischemic stroke 0.1545 0.027 
Osteoporosis 0.0456 0.009 
Low back pain 0.1127 0.020 
Depression 0.1996 0.039 
Source: GBD Results Tool 33,65 
 
Health care costs related to the medical treatment of diseases were derived from the literature (Table 6).53,66-68 
For breast and colon cancer, we used different annual costs for different treatment phases: for the first year, for 
subsequent years, and for the last year before death.66,67 For all other diseases, we had to use constant costs along 
the disease pathway due to data availability. Where needed, costs were transferred to Swiss francs (CHF), first 
adjusting for different amounts of healthcare resources used according to purchasing power parity per capita 
health care spending, and second adjusting for different price levels in the reference country compared to 
Switzerland.69 Furthermore, costs were inflated to 2018 values based on changes in per capita healthcare 
spending in Switzerland.70 We further estimated age‐standardized per capita healthcare spending for each 
language region based on the statistics of the Swiss risk compensation scheme to allow for regional differences 
in health care spending.71 
 
 
 
 
Table 6 Annual direct medical costs per patient by region in CHF and USD for 2018 
Disease Region Costs, 2018 CHF Costs, 2018 USD 
Breast cancer, incident 
Switzerland 
 43,959.87   36,941.07  
Breast cancer, prevalent  5,215.89   4,383.10  
Breast cancer, terminal  62,303.28   52,355.70  
Colorectal cancer, incident  73,017.82   61,359.52  
Colorectal cancer, prevalent  6,484.21   5,448.91  
Colorectal cancer, terminal  145,753.73   122,482.12  
T2DM 7,770.37 6,529.72 
Coronary heart disease 6,617.99 5,561.33 
Ischemic stroke 23,686.49 19,904.61 
Low back pain 9,360.94 7,866.33 
Osteoporosis 2,506.91 2,106.65 
Depression 5,740.96 4,824.33 
Breast cancer, incident 
French-speaking region 
 47,580.81   39,983.87  
Breast cancer, prevalent  5,645.52   4,744.13  
Breast cancer, terminal  67,435.15   56,668.19  
Colorectal cancer, incident  79,032.24   66,413.65  
Colorectal cancer, prevalent  7,018.31   5,897.74  
Colorectal cancer, terminal  157,759.34   132’570.87  
T2DM 8,410.41 7,067.57 
Coronary heart disease 7,163.10 6,019.42 
Ischemic stroke 25,637.52 21,544.14 
Low back pain 10,131.99 8,514.28 
Osteoporosis 2,713.41 2,280.17 
Depression 6,213.84 5,221.71 
Breast cancer, incident 
German-speaking 
region 
 42,482.43   35,699.52  
Breast cancer, prevalent  5,040.59   4,235.79  
Breast cancer, terminal  60,209.34   50,596.09  
Colorectal cancer, incident  70,563.78   59,297.30  
Colorectal cancer, prevalent  6,266.28   5,265.78  
Colorectal cancer, terminal  140,855.12   118,365.64  
T2DM 7,509.21 6,310.26 
Coronary heart disease 6,395.56 5,374.42 
Ischemic stroke 22,890.41 19,235.64 
Low back pain 9,046.33 7,601.96 
Osteoporosis 2,422.66 2,035.85 
Depression 5,548.01 4,662.19 
Breast cancer, incident 
Italian-speaking region 
 46,212.36   38,833.92  
Breast cancer, prevalent  5,483.15   4,607.69  
Breast cancer, terminal  65,495.68   55,038.39  
Colorectal cancer, incident  76,759.23   64,503.56  
Colorectal cancer, prevalent  6,816.46   5,728.12  
Colorectal cancer, terminal  153,222.10   128,758.07  
T2DM 8,168.52 6,864.30 
Coronary heart disease 6,957.09 5,846.29 
Ischemic stroke 24,900.17 20,924.52 
Low back pain 9,840.59 8,269.40 
Osteoporosis 2,635.37 2,214.60 
Depression 6,035.12 5,071.53 
Source: Cost data derived from literature 53,66-68. Inflation from 2013 to 2018 values based on nominal healthcare 
cost changes in Switzerland 70. 
Abbreviations: CHF, Swiss francs; T2DM, Type 2 Diabetes Mellitus. 
 
Annual productivity losses due to morbidity and informal care for each disease were derived from literature 
(Tables 7-9).53,68 Productivity losses due to mortality before the age of retirement (65 years in Switzerland) were 
estimated by applying sex- and region-specific median salaries for 2018. Median salaries were sourced from the 
Swiss Earnings Structure Survey 2016 and extrapolated using the nominal wage index.72 We also considered the 
 
 
 
 
proportion of people employed and the degree of employment based on the Swiss Labor Force Survey.73 Fifteen 
percent was added to the median salary to account for the mandatory social contributions paid by employers in 
Switzerland. Future effects and costs were discounted at 3% per annum. 
 
Table 7 Annual productivity losses due to morbidity and informal care per patient by region in CHF and 
USD for 2018 
Disease Region Costs, 2018 CHF Costs, 2018 USD 
Breast cancer 
Switzerland 
24,103.67 20,255.18 
Colorectal cancer 26,921.77 22,623.34 
T2DM 2,916.99 2,451.25 
Coronary heart disease 2,970.04 2,495.83 
Ischemic stroke 7,452.76 6,262.82 
Low back pain 16,442.82 13,817.50 
Osteoporosis n/a n/a 
Depression 6,316.86 5,308.28 
Breast cancer 
French-speaking region 
24,092.65 20,245.93 
Colorectal cancer 26,909.47 22,613.00 
T2DM 2,915.66 2,450.13 
Coronary heart disease 2,968.68 2,494.69 
Ischemic stroke 7,449.35 6,259.96 
Low back pain 16,435.31 13,811.18 
Osteoporosis n/a n/a 
Depression 6,313.97 5,305.86 
Breast cancer 
German-speaking region 
24,312.98 20,431.07 
Colorectal cancer 27,155.55 22,819.79 
T2DM 2,942.32 2,472.54 
Coronary heart disease 2,995.83 2,517.50 
Ischemic stroke 7,517.48 6,317.21 
Low back pain 16,585.61 13,937.49 
Osteoporosis n/a n/a 
Depression 6,371.71 5,354.38 
Breast cancer 
Italian-speaking region 
20,622.52 17,329.85 
Colorectal cancer 23,033.62 19,355.98 
T2DM 2,495.70 2,097.23 
Coronary heart disease 2,541.09 2,135.37 
Ischemic stroke 6,376.40 5,358.32 
Low back pain 14,068.08 11,821.92 
Osteoporosis n/a /na 
Depression 5,404.55 4,541.64 
Source: Productivity losses derived from the literature.53,68 
Abbreviations: CHF, Swiss francs; T2DM, Type 2 Diabetes Mellitus; n/a, not applicable as all patients older 65 
years 
 
 
 
 
 
Table 8 Productivity losses due to presenteeism, absenteeism, early retirement and informal care per 
patient per disease for Switzerland in CHF for 2018 
Disease Presenteeism Absenteeism Early retirement Informal care Sum 
Breast cancer nr  11,341.95   12,753.65  24,103.67 
Colorectal cancer nr  12,668.01   14,244.75  26,921.77 
T2DM nr  525.52   2,391.46  nr 2,916.99 
Coronary heart disease nr  1,410.21  nr  1,559.82  2,970.04 
Ischemic stroke nr  3,538.67  nr  3,914.09  7,452.76 
Low back pain  7’260.41   2,770.59   6,411.82   -    16,442.82 
Osteoporosis  n/a    n/a    n/a    n/a n/a    
Depression nr     5,625.64   691.22  nr 6,316.86 
Source: Productivity losses derived from the literature.53,68 
Abbreviations: CHF, Swiss francs; T2DM, Type 2 Diabetes Mellitus; n/a, not applicable as all patients older 65 
years; nr, not reported 
 
Table 9 Median annual region-specific salaries used in SPACE 
Sex Region Salary, 2018 CHF Salary, 2018 USD 
Women Switzerland 35,412 29,764 
Women French-speaking region 35,400 29,748 
Women German-speaking region 35,725 30,021 
Women Italian-speaking region 30,304 25,466 
Men Switzerland 59,695 50,164 
Men French-speaking region 59,661 50,135  
Men German-speaking region 60,210 50,597 
Men Italian-speaking region 51,074 42,919 
Source: Swiss Earnings Structure Survey72 
Abbreviations: CHF, Swiss francs; USD, US dollars. 
 
 
 
 
3 Sensitivity analysis 
We conducted multiple scenario analyses and a probabilistic sensitivity analysis. The values of the following 
input parameters were varied as part of the scenario analyses: 
• population age (35 to 80 years) 
• discount rate (0% and 6%) 
• disease incidence trend (none) 
• health care costs and productivity losses (70% and 130%) 
• intervention effects and costs (70% and 130%) 
• duration of intervention effect (1 year and 5 years) 
• population reached (GP referral and exercise prescription: 5% and 15%; pedometer and individualized 
advice: 1% and 5%) 
• METs assigned (4 instead of 3 METs to low/moderate physical activity and 8 instead of 6 to high 
intensity physical activity) 
Furthermore, we investigated the impact of considering the additional three diseases compared to the five “core” 
diseases. 
A probabilistic sensitivity analysis (PSA) was also conducted. We used the following distributions for key input 
variables: normal distributions for intervention effects, beta distributions for the annual decay of intervention 
effect and disability weights, gamma distributions for health care cost and productivity losses, and lognormal 
distribution for RRs. Whenever possible, we used the lower and upper bounds of the 95% confidence interval or 
the standard error to characterize uncertainty. Where information on the uncertainty was unavailable, we 
assumed a standard error of 10% of the reported point estimate. A total of 2,000 simulations were run. 
 
 
 
 
 
4 Results 
Figure 2 Cost-effectiveness planes, societal perspective 
   
   
 
 
 
 
 
Figure 3 Cost-effectiveness planes, health care payer perspective 
   
   
 
 
 
 
 
 
 
Figure 4 Net costs tornado diagrams for the scenario analysis for all four interventions, national level, societal perspective 
   
   
Blue bars indicate the impact of parameter values lower than the corresponding base case values; red bars indicate the impact of higher parameter values. 
 
 
 
 
Figure 5 DALYs tornado diagrams for the scenario analysis for all four interventions, national level, societal perspective 
   
   
Blue bars indicate the impact of parameter values lower than the corresponding base case values; red bars indicate the impact of higher parameter values. 
 
 
 
 
Table 10 Detailed results scenario analysis 
 DALYs 
averted 
Net cost, societal 
perspective (in CHF) 
Net cost, health care payer 
perspective (in CHF) 
Pedometer    
Base case 133.1  -12,230,213   -3,297,857  
Population age (35-80y) 160.6  -14,910,170   -4,237,074  
Discount factor (0%) 175.8  -14,691,616   -5,088,978  
Discount factor (6%) 108.8  -10,457,127   -2,093,706  
Effect duration (1year) 78.0  -4,475,514   963,366  
Effect duration (5 years) 146.0  -13,927,178   -4,275,038  
MET-min assigned (4/8) 130.7  -11,412,096   -3,001,141  
Population reached (1%) 44.4  -2,610,071   367,381  
Population reached (5%) 221.8  -21,850,354   -6,963,095  
Health care costs and prod. losses (70%) 133.1  -6,494,170   -175,721  
Health care costs and prod. losses (130%) 133.1  -17,966,256   -6,419,993  
Epi data (GBD + Swiss data) 177.8  -19,079,718   -6,560,689  
Disease trends (no) 132.9  -12,178,234   -3,266,402  
Intervention cost (70%) 133.1  -14,362,992   -5,430,636  
Intervention cost (130%) 133.1  -10,097,434   -1,165,078  
Intervention effect (70%) 94.6  -6,801,602   -340,237  
Intervention effect (130%) 171.7  -17,668,496   -6,261,427  
Diseases included (only 5 "core") 58.0  2,474,153   3,343,685  
    
GP referral    
Base case 306.2  -13,352,771   7,056,219  
Population age (35-80y) 389.0  -15,310,004   9,202,980  
Discount factor (0%) 418.0  -18,219,776   3,698,812  
Discount factor (6%) 244.4  -9,678,901   9,443,635  
Effect duration (1year) 178.9  3,755,776   16,194,193  
Effect duration (5 years) 336.5  -17,084,255   4,957,494  
MET-min assigned (4/8) 308.5  -13,653,912   6,900,667  
Population reached (1%) 153.1  -6,171,386   4,033,110  
Population reached (5%) 459.3  -20,534,157   10,079,329  
Health care costs and prod. losses (70%) 306.2  -746,162   13,753,302  
Health care costs and prod. losses (130%) 306.2  -25,959,381   359,136  
Epi data (GBD + Swiss data) 383.6  -28,130,916   81,952  
Disease trends (no) 305.6  -13,222,612   7,133,523  
Intervention cost (70%) 306.2  -22,166,720   -1,757,729  
Intervention cost (130%) 306.2  -4,538,823   15,870,167  
Intervention effect (70%) 214.5  -527,716   13,751,957  
Intervention effect (130%) 398.0  -26,192,479   353,876  
Diseases included (only 5 "core") 151.1  19,488,443   21,435,834  
    
Individualized advice    
Base case 142.7  -16,594,203   -7,043,899  
Population age (35-80y) 172.2  -20,439,956   -9,028,765  
Discount factor (0%) 188.6  -19,234,034   -8,966,522  
Discount factor (6%) 116.6  -14,693,526   -5,751,889  
Effect duration (1year) 83.6  -8,294,160   -2,479,256  
Effect duration (5 years) 156.5  -18,410,797   -8,090,837  
MET-min assigned (4/8) 140.5  -15,808,643   -6,766,414  
Population reached (1%) 47.6  -3,464,734   -281,300  
Population reached (5%) 237.8  -29,723,672   -13,806,498  
Health care costs and prod. losses (70%) 142.7  -10,455,832   -3,699,876  
Health care costs and prod. losses (130%) 142.7  -22,732,574   -10,387,921  
Epi data (GBD + Swiss data) 190.5  -23,922,087   -10,535,713  
Disease trends (no) 142.5  -16,538,601   -7,010,205  
Intervention cost (70%) 142.7  -17,825,056   -8,274,751  
Intervention cost (130%) 142.7  -15,363,350   -5,813,046  
Intervention effect (70%) 101.3  -10,757,893   -3,864,178  
Intervention effect (130%) 184.3  -22,443,556   -10,231,712  
Diseases included (only 5 "core") 62.3  -880,069   54,725  
    
Exercise prescription    
Base case 222.5  -5,675,603   9,138,849  
Population age (35-80y) 282.6  -6,071,797   11,721,564  
Discount factor (0%) 303.7  -9,212,450   6,698,141  
Discount factor (6%) 177.5  -3,006,461   10,873,946  
Effect duration (1year) 130.0  6,744,182   15,774,192  
Effect duration (5 years) 244.4  -8,385,153   7,614,597  
MET-min assigned (4/8) 224.0  -5,888,691   9,030,113  
Population reached (1%) 111.2  -2,332,802   5,074,424  
 
 
 
 
 DALYs 
averted 
Net cost, societal 
perspective (in CHF) 
Net cost, health care payer 
perspective (in CHF) 
Population reached (5%) 333.7  -9,018,405   13,203,273  
Health care costs and prod. losses (70%) 222.5  3,477,330   14,002,496  
Health care costs and prod. losses (130%) 222.5  -14,828,537   4,275,202  
Epi data (GBD + Swiss data) 278.6  -16,390,838   4,081,423  
Disease trends (no) 222.0  -5,581,151   9,194,969  
Intervention cost (70%) 222.5  -13,280,905   1,533,547  
Intervention cost (130%) 222.5  1,929,698   16,744,150  
Intervention effect (70%) 155.7  3,639,511   14,005,125  
Intervention effect (130%) 289.1  -14,988,509   4,276,705  
Diseases included (only 5 "core") 109.9  18,157,126   19,573,849  
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 Discussion 
Before this PhD project started, evidence showed that physical inactivity causes a substantial 
health and economic burden globally [47, 49]. For Switzerland, there was research available 
investigating the burden of physical inactivity [22]. However, this research estimated the 
burden for the entire country without differentiating between sub regions although the 
prevalence of physical inactivity varies significantly between Swiss language regions [8]. 
Therefore, the aim of the first publication forming part of this PhD thesis was to estimate the 
burden of physical inactivity in Switzerland separately for the German-, French- and Italian-
speaking regions [1]. As this first PhD publication showed a substantial burden of physical 
inactivity in the Swiss language regions, we investigated interventions aiming to increase 
physical inactivity in a systematic review that underlies the second publication forming part of 
this PhD thesis [2]. We then moved on and used findings from the first two PhD publications 
to develop a health economic model that investigates the cost-effectiveness of physical activity 
interventions in Switzerland and its three language regions [3]. The cost-effectiveness model 
has recently been submitted for publication. This chapter summarizes the main findings of the 
two publications forming part of this PhD thesis and the paper that has been submitted for 
publication, discusses them and provides prospects for future research.  
 
 Summary of findings 
6.1.1 Aim 1: Burden of physical inactivity in Swiss language regions [1] 
We estimated the burden of physical inactivity in Swiss adults from a societal perspective with 
a prevalence‑based top‑down approach using population attributable fractions (PAFs) and the 
latest data available for Switzerland. The following nine diseases related to physical inactivity 
were included in the analysis: coronary heart disease, hypertension, ischemic stroke, type 2 
diabetes mellitus, breast cancer, colorectal cancer, osteoporosis, low back pain, and 
depression. Total DALYs, health care costs, and productivity losses of these diseases were 
then retrieved from the global burden of disease (GBD) study and a recent study of the costs 
of NCDs in Switzerland. In order to analyze the fraction of this total burden that is attributable 
to physical inactivity, we combined estimates of the prevalence of physical inactivity stemming 
from the Swiss Health Survey in 2012 with literature‑based estimates of disease incidence in 
the presence vs. absence of physical inactivity and resulting relative risks (RRs). The 
combination of these two types of parameters allowed us to estimate PAFs, which describe 
the proportion of disease occurrence that can be attributed to a certain risk factor.  
The burden of physical inactivity in Switzerland in 2013 was estimated at CHF 1.610 billion 
(95%CI CHF 1.413‑1.827 billion) plus 40,433 (95%CI 34,935‑46,487) DALYs. The DALYs lost 
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due to physical inactivity represented 2.0% (95%CI 1.7%‑2.2%) of total DALYs lost in 
Switzerland. Osteoporosis contributed 34.4% of the DALYs, low back pain 17.7%, 
cardiovascular diseases 21.9%, and depression 8.3%. Health care costs caused by physical 
inactivity were estimated at CHF 0.802 billion (95%CI CHF 0.684‑0.934 billion) or at 1.2% 
(95%CI 1.0%‑1.3%) of total health care expenditures. This was equivalent to CHF 116 (95%CI 
CHF 99‑135) per capita. Of these health care costs, 35.4% were attributed to cardiovascular 
diseases (coronary heart disease, ischemic stroke, and hypertension), 20.9% to low back pain, 
17.5% to depression, and the remaining 26.2% to osteoporosis, type 2 diabetes mellitus, 
colorectal cancer, and breast cancer. Productivity losses were valued at CHF 0.808 billion 
(95%CI CHF 0.653‑0.983 billion) or CHF 117 (95%CI CHF 94‑142) per capita and were mainly 
caused by low back pain (38.2%), depression (20.0%), and cardiovascular diseases (17.9%). 
Furthermore, we found that the French‑ and Italian‑speaking regions, which are home to 30% 
of the Swiss population, contribute more than 45% to the burden of physical inactivity. Reasons 
include a higher prevalence of physical inactivity, higher per capita health care spending, and 
higher disease prevalence than the German‑speaking region. In addition, the per capita burden 
was twice as high in the French- and Italian-speaking regions compared to the German-
speaking region. In the German-speaking region, we estimated per capita health care costs 
due to physical inactivity at CHF 87, productivity losses at CHF 96, and DALYs per 1,000 
persons at 4.5. Health care costs in the French‑speaking region were estimated at CHF 179 
per capita, productivity losses at CHF 164, and DALYs at 8.9 per 1,000 persons. In the Italian‑
speaking region, per capita health care costs were valued at CHF 172, productivity losses at 
CHF 153, and DALYs per 1,000 persons at 8.6. 
In conclusion, this study showed that physical inactivity causes a substantial health and 
economic burden in Swiss adults and that the French‑ and Italian‑speaking regions are over- 
proportionally affected. Investments in interventions aiming to increase physical activity should 
therefore be considered. Such interventions should be cost-effective and this study indicates 
that regional differences likely influence the cost-effectiveness of physical activity 
interventions. Furthermore, this study showed that low back pain and depression substantially 
add to the burden of physical inactivity. Consequently, future studies should consider these 
two diseases when estimating the burden of physical inactivity. 
 
6.1.2 Aim 2: Systematic review of cost-effectiveness of physical activity 
interventions [2] 
In this systematic review, we aimed to summarize evidence from RCT-based economic 
evaluations of primary prevention physical activity interventions in adult populations outside 
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the workplace setting. We included cost-effectiveness analyses in which all data (except unit 
costs) came from one RCT. As the studies reported different physical activity outcomes, effect 
measures were standardized in metabolic equivalent of task (MET)-hours gained per person 
per day. We further calculated the mean differences in costs and outcomes between 
intervention and control as a basis for estimating the ICER in US$ per MET-hour gained. A 
benchmark between US$0.44 and US$0.63 per MET-hour gained, which was based on the 
health care costs and productivity losses of physical inactivity in Switzerland, was used to 
assess the cost-effectiveness of interventions. 
Twelve studies published between 2000 and 2018 were included in the final analysis. In these 
twelve studies, 22 interventions were investigated. Interventions were based on advice, goal 
setting and follow-up support, exercise classes, financial incentives or teaching on behavioral 
change. The effects and the costs of the interventions varied widely and so did the ICER. Four 
interventions showed an ICER below the applied benchmark. These four interventions were 
based on individualized advice delivered in four different ways: print (postal mail) or web 
(website and email) and in a basic form (standard advice) or with additional environmental 
components (e.g., walking and cycling routes and physical activity possibilities and initiatives 
in participants’ own neighborhood and home exercises). One other intervention that was based 
on behavior change counseling by telephone had an ICER of US$0.64 per MET-hour gained. 
One pedometer-based individualized step-related goal setting intervention had an ICER of 
US$0.67 per MET-hour gained [39]. Another intervention was based on face-to-face advice, 
goal setting, follow-up face-to-face meeting and follow-up telephone counseling [36]. This 
intervention had an ICER of US$0.85 per MET-hour gained. All other interventions had an 
ICER above US$1.00 per MET-hour gained. 
In conclusion, we found evidence from RCTs indicating cost-effectiveness of some physical 
activity interventions for primary prevention in adults. However, cost-effectiveness results 
varied widely among interventions and the majority of interventions would not be cost-effective 
according to the benchmark applied. Four interventions that delivered individualized advice via 
print or web showed best value (physical activity gains) for money (intervention costs). Our 
study also showed that trial-based evidence on the cost-effectiveness of physical activity 
interventions is relatively scarce. Therefore, we recommend that future studies investigating 
the efficacy or effectiveness of interventions aimed at increasing physical activity consider 
costs as an additional outcome and assess cost-effectiveness. 
 
6.1.3 Aim 3: Cost-effectiveness model of physical activity interventions [3] 
The cost-effectiveness model of physical activity interventions was built as a proportional 
multistate life table model for the Swiss adult population over their lifetime. We named it the 
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Swiss Physical Activity Cost-Effectiveness (SPACE) model. In the model, a comprehensive 
set of diseases was included, namely breast cancer, colorectal cancer, type 2 diabetes 
mellitus, coronary heart disease, ischemic stroke, osteoporosis, low back pain and depression. 
The effect of interventions on diseases was modelled with data from recent meta-analyses. 
Interventions analyzed were individualized physical activity advice, pedometer with 
individualized goal setting, general practitioner (GP) referral for telephone-based counseling 
and exercise prescription. Intervention effects were taken from RCTs and intervention costs 
were based on a bottom-up approach with Swiss prices. Cost-effectiveness in terms of cost 
per DALY averted compared to “doing nothing” as well as cost-effectiveness between 
interventions were analyzed on the national level and separately for the French-, German- and 
Italian-speaking language regions. The frequently assumed tentative willingness-to-pay 
threshold of CHF 100,000 per DALY was used to assess the cost-effectiveness of 
interventions. Interventions that led to better health and were at the same time cost-saving 
were categorized as “dominant”. 
From a societal perspective and irrespective of language region, all four interventions were 
cost-saving and more effective compared to “doing nothing”. At the national level and in the 
German-speaking region, individualized advice was the preferable intervention followed by GP 
referral. These two interventions dominated pedometer and exercise prescription. In the 
French- and Italian speaking regions, GP referral was the preferable intervention that 
dominated the three others. From a health care payer perspective, however, individualized 
advice was the preferable intervention followed by GP referral. The uncertainty underlying key 
model input parameters led to substantial variation in the modelled results, according to the 
probabilistic sensitivity analysis. 
In conclusion, we hope to inform efficient resource allocation and evidence-based decision-
making in primary prevention in Switzerland. We recommend that individualized advice and 
GP referral be further evaluated as interventions and that decision-making considers the 
specifics of the Swiss language regions. Furthermore, we judge the SPACE model to be not 
only relevant for Switzerland but also for other multicultural countries. Based on similar data 
availability, the SPACE model has the potential to be applied beyond Switzerland, primarily to 
high-income countries with a comparable background, as a tool to guide societal efforts in 
primary prevention of physical-inactivity-related diseases. 
 
 126 
 General discussion 
6.2.1 Diseases related to physical inactivity 
The following five diseases can be considered the “core set of diseases related to physical 
inactivity” as they are frequently used in health economic studies investigating physical activity 
[96, 97, 100]: breast cancer, colorectal cancer, type 2 diabetes mellitus, coronary heart disease 
and ischemic stroke. Osteoporosis, low back pain and depression have been taken into 
account less frequently [94, 122, 123]. However, it has recently been shown that physical 
activity reduces incidence of these three diseases [31, 32, 122]. Consequently, we included 
them in the first PhD paper (burden of physical inactivity) as well as in the third (cost-
effectiveness model of interventions). In the first paper, we showed that all three diseases 
substantially add to the burden of physical inactivity. In the third paper, these three diseases 
had a substantial influence on the cost-effectiveness of interventions. Consequently, it can be 
suggested that future studies investigating the burden of physical inactivity include 
osteoporosis, low back pain and depression. In addition, the inclusion of the three diseases 
can be recommended for cost-effectiveness models investigating physical activity 
interventions. 
While we included hypertension in the first PhD paper, we no longer considered it in the third 
paper. Hypertension is modelled as a disease in its own right in some studies [97, 124] or as 
part of cardiovascular diseases [125] or as a risk factor for cardiovascular diseases [126]. As 
the impact of hypertension on the burden of physical inactivity was rather small in the first PhD 
paper and we did not specifically model other risk factors for the diseases included, we did not 
consider hypertension in the cost-effectiveness model. 
Obesity was also not included as a specific primary disease in either the first or the third PhD 
paper, as the main burden related to obesity was considered to be caused by cardiovascular 
diseases and type 2 diabetes mellitus. Therefore, obesity was considered a risk factor rather 
than a disease on its own. This is in line with many other health economic studies investigating 
physical inactivity [90-97, 99, 100, 102]. 
Although we tried to be comprehensive with diseases related to physical inactivity, there may 
be other diseases for which physical inactivity will be established as a risk factor such as 
dementia and Alzheimer’s disease [127-130]. Due to conflicting evidence, however, these 
diseases were not included in our work [131]. A recently-published, very extensive scientific 
report also found strong evidence that greater amounts of physical activity are associated with 
reduced risk of developing bladder cancer, endometrial cancer, esophageal cancer, gastric 
cancer, renal cancer, and anxiety disorders [24]. These diseases may be included in future 
studies investigating the health economic aspects of physical inactivity. 
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6.2.2 Cost-effectiveness evaluation of physical activity interventions 
The cost-effectiveness evaluation of physical inactivity interventions is subject to several 
challenges. For example, the ICER benchmark applied in the second PhD paper (between 
US$0.44 and US$0.63 per MET-hour gained, which is equal to CHF 0.53 and CHF 0.76 per 
MET-hour gained for 2018) was based on 2.5 hours of moderate intensity physical activity (at 
3 METs) per week and the per capita costs of physical inactivity in Switzerland. As 
approximately one quarter of the Swiss population is physically inactive, the cost per capita for 
the physically inactive ones is four times higher than for the total population. Therefore, the 
benchmark for an intervention targeting specifically the inactive people would be approximately 
four times higher, i.e. between CHF 2 and CHF 3 per MET-hour gained. Consequently, there 
is no particular benchmark to use for the cost-effectiveness evaluation of physical activity 
interventions. Furthermore, the outcome will depend on the different types of costs considered 
for the intervention under evaluation (intervention costs, health care costs offset, productivity 
losses offset). Further aspects that influence the cost-effectiveness include: the target 
population (e.g. general population or specifically the inactive ones), the population reached 
(e.g. 1%, 3%, 5%), and the time horizon considered. As some of these aspects cannot be 
evaluated in trials, health economic modelling will always play an important role for the 
evaluation of the cost-effectiveness of physical activity interventions. Therefore, the 
combination of within-trial cost-effectiveness analysis and beyond-trial modelling, as recently 
published by Harris et al. [132], may become a widely used method in the future. Modelling 
also allows for a relatively simple estimation of DALYs averted (or QALY gained). Such more 
generic outcomes, in comparison to a physical activity specific outcome like MET-hours 
gained, make it possible to compare interventions between different risk factors for NCDs (e.g. 
smoking, diet, etc) or compare interventions with other treatments for primary or secondary 
prevention. 
6.2.3 Cost-effectiveness studies run the risk of favoring interventions that only 
add small benefit 
Wu et al. [88] showed previously that some interventions that increased physical activity levels 
only by small amounts, such as stair climbing prompts, may be very cost-effective due to the 
very low intervention costs. This finding was supported by the results from the second PhD 
publication where the intervention investigated by Golsteijn et al. [133] that provided 
individualized advice delivered via web and included additional environmental components 
was the most cost-effective. The intervention itself had a negative effect of -0.06 MET-hours 
gained per person per day when comparing physical activity at the one-year follow-up with 
baseline. However, compared to the “doing nothing” control group, the incremental effect was 
0.26 MET-hours gained per person per day, which is equivalent to approximately 5 min of 
moderate physical activity per person per day. Although this is a positive effect, it can be 
 128 
considered a relatively low incremental physical activity gain that is not sufficient to lead to 
substantial health benefits [35]. The annual intervention costs were US$25.14 per person. This 
led to an ICER of US$0.27 per MET-hour gained, which was below the benchmark of between 
US$0.44 and US$0.63 per MET-hour gained applied in this study. Therefore, the intervention 
was considered cost-effective although the physical activity gain can be considered insufficient 
to lead to substantial health benefits. These findings were also confirmed in the third PhD 
paper, where we also included the intervention by Golsteijn et al. [133]. Consequently, relying 
on cost-effectiveness alone might favor interventions that are unable to add substantial health 
benefits. Therefore, we recommend that the specifics of each intervention should be 
considered and additional criteria such as minimal clinically-relevant effectiveness thresholds 
might be used in future physical activity policy decision-making. 
6.2.4 Regional differences in physical inactivity and their consequences for 
policy making 
In Switzerland, 24.3% of the population over the age of 15 is physically inactive [8]. However, 
the prevalence of physical inactivity shows significant regional differences: 21.0% of the adult 
population in the German-speaking region is physically inactive whereas 32.6% are physically 
inactive in the French-speaking region and 31.5% in the Italian-speaking region [8]. Due to this 
difference in the prevalence of physical inactivity and other differences such as per capita 
health care spending and disease prevalence, we showed in the first PhD paper that the per 
capita burden of physical inactivity is twice as high in the French- and Italian-speaking regions 
as in the German-speaking region [1]. Furthermore, the cost-effectiveness of physical activity 
interventions differed between language regions, as investigated in the third PhD paper [3]. In 
this paper, we showed that in regions with higher prevalence of physical inactivity, more costly 
interventions can still be cost-effective. These findings suggest that physical inactivity is 
tackled language-region specifically in Switzerland. This may also be the case for other risk 
factors for NCDs as they also show substantial regional variation [8]. 
6.2.5 Summary of strength and limitations 
This PhD thesis has a number of strengths, but also some limitations that should be 
considered. One major strength is the societal perspective chosen for the cost assessment, 
i.e. the incorporation of productivity losses. Previous studies mainly focused on health care 
costs, while Briggs et al. [99] also included social care costs for ages above 75 years. A further 
strength of this thesis was the comprehensive set of diseases included. Besides the “core set 
of diseases related to physical inactivity” (breast cancer, colorectal cancer, type 2 diabetes 
mellitus, coronary heart disease and ischemic stroke), we also considered osteoporosis, low 
back pain and depression. These three additional diseases substantially added to the burden 
of physical inactivity and influenced the cost-effectiveness of interventions. An additional 
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strength of the thesis is the language-region-specific analyses made. While the study by Roux 
et al. [112] analyzed cost-effectiveness separately for different age groups, many other models 
investigating physical activity interventions focused on entire countries without analyzing 
subgroups. In Switzerland, where the prevalence of physical inactivity substantially differs 
between language regions, the regional analysis was shown to be crucial to allocate resources 
efficiently. Furthermore, we considered fixed and variable intervention costs separately when 
assessing the cost-effectiveness of physical activity interventions to account for the fact that 
the use of certain resources is independent from the number of people receiving the 
intervention [115]. Our findings showed that the separation of fixed and variable intervention 
costs may substantially influence cost-effectiveness when the scale of the intervention 
substantially differs. 
The main limitation of the thesis is the uncertainty arising from the use of secondary data 
sources. For example, the RR we used for our calculations are not based on a standardized 
definition and measurement of physical activity and a standardized assessment of 
confounding. We also assumed equal RR across gender and age‑groups. In addition, 
intervention effect measures were standardized to MET-hours gained per person per day. 
Although this method was used in previous studies, it may have some limitations when applied 
to broad outcomes such as step gains or proportions of populations meeting physical activity 
guidelines [88, 134]. Moreover, many studies did not report sufficient statistical detail and, 
therefore, we were not able to properly address the uncertainty of effect measures. 
A further limitation is that response in the Swiss Health Survey was non‑random. For instance, 
responders were of higher average socioeconomic status and reported better subjective health 
than non‑responders [135]. This may have affected our estimates of prevalence of physical 
activity categories as well as MET-minutes assigned to each physical activity category. 
Furthermore, we may have underestimated the prevalence of physical inactivity as the Swiss 
Health Survey investigates self‑reported activity levels. According to a recent study from 
Switzerland, time spent physically active was 4.2 times higher when self‑reported compared 
to measurements with accelerometers [136]. Several other studies also showed substantial 
differences between self-reported physical activity and objective measurements [137]. Our 
estimates are consistent in at least the sense that both prevalence and RR were based on self‑
reported physical activity levels.  
As a further limitation, the productivity losses estimated were based on limited data available 
from the literature. For some domains such as presenteeism, early retirement and informal 
care, values were not reported in the literature. Therefore, we likely underestimated the true 
productivity losses due to morbidity and informal care. 
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Regarding the language-region-specific analyses, the following aspects were considered in 
the model: population counts, prevalence of physical activity categories, disease costs, 
productivity losses and fixed intervention costs. Other aspects were assumed to be the same, 
mainly due to lack of region-specific data: intervention effect, variable intervention costs, 
disease incidence, disease-specific mortality and disability weights. 
Furthermore, we focused on interventions that can be implemented on a population-level and 
therefore excluded studies investigating the workplace setting. However, some interventions 
focusing on the workplace setting have been previously shown to be cost-effective [138]. By 
limiting the study design to RCTs, we also excluded interventions targeting the built 
environment [88, 134, 139, 140]. As we excluded studies that did not report specific physical 
activity outcomes, we did not include studies only reporting quality-adjusted life-years as part 
of pure cost-utility analyses [125, 141, 142]. These studies showed varying results in terms of 
cost per quality-adjusted life-years gained by physical activity interventions. 
In regard to the burden of physical inactivity, it is also noteworthy that we only investigated the 
impact of physical activity on primary prevention. There are several diseases in which physical 
activity is an effective modifier of the course of clinical disease, and one could argue that there 
is an additional burden related to inactive patients [143]. In addition, we did not consider costs 
of myocardial infarctions occurring during physical activity and costs of sport injuries. However, 
there is evidence that sport injuries especially happen to people that are not regularly active 
[144]. 
 
 Prospects for future research 
First of all, Switzerland would benefit from a Swiss burden of disease study. Such a study is 
suggested as we detected discrepancies between GBD data and data coming directly from 
Switzerland. Alternatively, Switzerland could further develop the collaboration with the GBD 
study to increase data consistency. However, the understanding of the true burden of disease 
in Switzerland is considered fundamental to adequately assess the burden of risk factors for 
diseases and the cost-effectiveness of interventions tackling those risk factors. Furthermore, 
DALYs have been confirmed as a very valuable complementary measure to number of deaths 
(mortality) and money (economic burden). In a society where quality of life is a very important 
good, it is time to make this measure more common. Another measure that goes even beyond 
morbidity, mortality and economic burden is well-being [145]. Well-being may be investigated 
as an additional, separate outcome in future studies. 
In addition, it is recommended to refine SPACE in such a way that it allows for a cost-
effectiveness evaluation of all behavioral risk factors for NCDs (i.e. smoking, alcohol abuse, 
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dietary risks and physical inactivity) in Switzerland. Multistate life table models like SPACE 
have already been used to assess interventions against smoking and unhealthy diet [146-155]. 
This would allow for a comprehensive understanding of NCDs and the cost-effectiveness of 
interventions tackling their risk factors. Such future models may not only address single risk 
factors but also multiple risk factor behavior [156-158]. 
The SPACE model currently contains data for the population from 15 to 100 years old. 
Consequently, children are excluded and the model does not allow for a holistic life course 
approach. Although different physical activity trajectories have been observed, the majority of 
the population seems to follow a persistent one [159]. In addition, better cardiovascular health 
indicators have been found in children who engage in higher levels of physical activity during 
early childhood [160]. This may influence cardiovascular health in adulthood. A holistic life 
course perspective may be taken in future models, which then would allow us to also analyze 
the cost-effectiveness of interventions targeting children.  
Although there is currently no agreement over the most appropriate approach, several studies 
suggest the consideration of equity in the economic evaluations of public health interventions 
[161]. Therefore, future versions of SPACE may also implement equity considerations. 
Last but not least, the SPACE model could serve as a template for estimating the cost-
effectiveness of physical activity interventions from a societal perspective in other multi-cultural 
countries. 
 
 Conclusions 
This thesis had three aims: 
1. Estimating the health and economic burden of physical inactivity in Switzerland and for 
the French-, German- and Italian-speaking language regions separately 
2. Systematically reviewing trial-based economic evaluations of interventions to reduce 
physical inactivity 
3. Developing a health economic model that investigates the cost-effectiveness of 
physical activity interventions in Switzerland and its three language regions 
The thesis showed that the burden of physical inactivity in Switzerland is substantial and that 
the French- and Italian-speaking regions are over-proportionally affected. These two regions 
distinguish themselves from the German-speaking region as they have a higher prevalence of 
physical inactivity, higher per capita health care spending, and higher disease prevalence. Due 
to the substantial burden of physical inactivity, interventions aiming to increase physical activity 
should be considered. In the systematic review we conducted, we found evidence from RCTs 
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indicating the cost-effectiveness of some physical activity interventions for primary prevention 
in adults. These interventions were then further evaluated in a cost-effectiveness model built 
for the Swiss setting. This model showed that Swiss policy makers have cost-effective options 
of physical activity promotion. We recommend that individualized advice and GP referral be 
further evaluated as interventions and that decision-making considers the specifics of the 
Swiss language regions. Furthermore, we judge the cost-effectiveness model to be not only 
relevant for Switzerland but also for other multicultural countries. Based on similar data 
availability, our model has the potential to be applied beyond Switzerland, primarily to high-
income countries with a comparable background, as a tool to guide societal efforts in primary 
prevention of physical-inactivity-related diseases. 
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